WO2018212627A1 - Mutant microorganism having enhanced succinic acid production capacity and succinic acid production method using same - Google Patents

Mutant microorganism having enhanced succinic acid production capacity and succinic acid production method using same Download PDF

Info

Publication number
WO2018212627A1
WO2018212627A1 PCT/KR2018/005742 KR2018005742W WO2018212627A1 WO 2018212627 A1 WO2018212627 A1 WO 2018212627A1 KR 2018005742 W KR2018005742 W KR 2018005742W WO 2018212627 A1 WO2018212627 A1 WO 2018212627A1
Authority
WO
WIPO (PCT)
Prior art keywords
strain
coli
succinic acid
gene
ptsg
Prior art date
Application number
PCT/KR2018/005742
Other languages
French (fr)
Korean (ko)
Inventor
이상준
김현주
Original Assignee
중앙대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 중앙대학교 산학협력단 filed Critical 중앙대학교 산학협력단
Publication of WO2018212627A1 publication Critical patent/WO2018212627A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/44Polycarboxylic acids
    • C12P7/46Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185Escherichia
    • C12R2001/19Escherichia coli

Definitions

  • the present invention relates to a method for producing a mutant microorganism having high succinic acid production capacity, and more particularly, by selecting and evolving a microorganism lacking genes involved in sugar transport under anaerobic conditions, selecting a fast-growing mutant strain. It relates to a microbial evolution engineering method for producing a fermentation product succinic acid in high yield or high productivity by culturing the strain artificially introduced strains identified in strains or mutant strains under anaerobic conditions.
  • Succinic acid is a four-carbon dicarboxylic acid, an organic acid with high industrial and economic value, widely used as a precursor for chemicals used in medicine, food, cosmetics and other industries.
  • BDO 1,4-butanediol
  • THF tetrahydrofuran
  • GBL gamma-butyrolactone
  • 2-pyrrolidone C4 series chemicals
  • PBS polybutyrene succinate
  • PBS polybutyrene succinate
  • polyesters a kind of biodegradable polymer. Large industrial applicability.
  • succinic acid Most of succinic acid currently used commercially is converted to maleic anhydride produced by petrochemical process into succinic anhydride by liquid phase hydrogenation reaction. Converted to succinic acid through a hydration reaction and produced.
  • succinic acid is produced as an intermediate in the TCA cycle and also as a final metabolic product of anaerobic fermentation.
  • succinic acid is produced from almost all microorganisms, from plants and animal cells, and in particular, it is known to produce a relatively large amount of succinic acid from bacteria isolated from rumens such as Aspergillus family of fungi and Actinobacillus and Mannheimia .
  • Succinic acid production through fermentation includes actinobacillus , Anaerobiospirillum and Mannheimia Succinic acid production using the strain has been much research.
  • MBI American Michigan Biotechnology Institute
  • researchers Actinobacillus succinogenes A 130Z strain (ATCC No.
  • succiniciproducens LPK (KCTC10558BP), a mutant strain from which the lactic acid dehydrogenase gene ( ldhA ) and the pyruvate-formatease gene ( pfl ) was deleted, was further produced. Furthermore, the mutant strain M was inhibited to inhibit the production of acetic acid. .
  • succiniciproducens LPK7 (KCTC10626BP) in which phosphotransacetylacetylase gene ( pta ) and acetic acid kinase gene ( ackA ) were deleted from LPK, was produced and cultured in anaerobic conditions to prepare succinic acid.
  • succiniciproducens PALK (KCTC10973BP) that was deleted, and then the strain was subjected to glucose and glycerol in anaerobic conditions. Fermented by using as a carbon source to minimize the growth rate of microorganisms and at the same time developed a mutant microorganism and fermentation method that can produce succinic acid in high yield by completely blocking the production of various by-products including pyruvic acid.
  • An object of the present invention is to provide a method for selecting a mutant microorganism strain showing a rapid growth rate and improved succinic acid production capacity by adaptively evolving a mutant microorganism strains genes related to the sugar transport system, and to identify a mutant target gene. It is another object of the present invention to provide a method for producing succinic acid in high yield or high productivity by anaerobic culture of a microorganism strain into which the adapted mutant microorganism or a mutant target gene is artificially introduced.
  • manX and ptsG gene is the or a further exuR or agaR gene deletion with the deletions of E. coli K-12 strain, exuR and agaR genes are both deleted E. coli K-12 mutant Provide strains.
  • the present invention also provides a succinic acid producing ability improved, in addition to the E. coli C strain manX and ptsG gene deletion or exuR agaR gene is a deletion or, exuR and agaR genes are both deleted Escherichia coli mutant strain C.
  • the present invention provides an E. coli C mutant strain having improved succinic acid production ability, in which agaW , agaE , agaF and agaA are deleted in addition to the E. coli C variant strain.
  • the present invention also ptsI gene is provided an adaptive evolution (adaptive evolution) as a strain obtained by the culture method, it enhanced E. coli K-12 mutant strain further the exuR gene ability deletions, succinic acid production in E. coli K-12 strain deleted .
  • the present invention also provides a succinic acid producing ability improved, ptsI gene is additionally exuR gene is an E. coli K-12 mutant strain deleted in a deletion of E. coli K-12 strain BW25113.
  • the present invention provides a method for producing succinic acid comprising the step of culturing the mutant strains to obtain succinic acid from the culture.
  • the present invention relates to a mutant microorganism having improved succinic acid production capacity and a succinic acid production method using the same, wherein when a gene involved in sugar transport of a microorganism is deleted in anaerobic conditions, it is a mutation of a sugar transport-related transcriptional regulator produced by adaptive evolution. Due to the production of fermentation products, such as lactic acid, ethanol is reduced, obtain a mutant microorganism having the characteristic of producing succinic acid at a high concentration, and by culturing the mutant microorganism to provide a method for producing succinic acid in high yield or high productivity have.
  • Figure 1 shows the growth and fermentation products of the parent strains HK907, HK898 and HK864 strain over time.
  • Figure 3 shows the mRNA expression level of the exuT gene of wild type strain (BW25113), parent strain (HK907) and adapted progeny strain (HK953) of K-12 strain.
  • Figure 4 shows the mRNA expression level of the exuT gene of wild type strain (KCTC2571), parent strain (HK864) and adapted progeny strain (HK878) of C strain.
  • the present invention was cultured until all the added glucose was consumed, from which the adapted progeny strains were obtained, and the strains were recovered through anaerobic culture, and the strains with improved succinic acid production capacity were selected.
  • the genomes of the mutant strains were identified through genome sequencing of the parent strains and progeny strains, and the gene complementarity test was used to determine whether the mutations of the identified genes affected the increase in succinic acid production.
  • a microbial evolution engineering method for producing a fermentation product succinic acid in high yield or high productivity by culturing the adapted progeny strain or artificially introduced strains identified in the progeny strain under anaerobic conditions was completed.
  • the present invention provides for further exuR gene is the E. coli K-12 mutant strain deleted for succinic acid production ability increased, the deletion manX E. coli ptsG gene and K-12 strains.
  • the present invention is further enhanced ability to produce succinic acid, and manX ptsG gene is deleted E. coli K-12 strain agaR Provided are E. coli K-12 variant strains that have been deleted.
  • the present invention is further exuR agaR and the succinic acid producing ability improved, manX ptsG gene and the E. coli K-12 strain BW25113 deletion Provided are E. coli K-12 variant strains that have been deleted.
  • the present invention also provides a succinic acid producing ability improved, manX ptsG gene and the gene deletion with the deletions are additionally exuR E. coli C strain E. coli C strain variation.
  • the E. coli C variant strain is Escherichia coli HK1014 strain described in the embodiment of the present invention, deposited with accession number KCTC13265BP.
  • the present invention also provides a succinic acid producing ability improved, manX ptsG gene and the gene deletion with the deletions are additionally agaR E. coli C strain E. coli C strain variation.
  • the present invention is further exuR agaR and the E. coli C strain with an improved, manX ptsG gene and acid production ability deletion Provided are E. coli C variant strains that have been deleted.
  • the invention also exuR agaR and the E. coli C strain is improved, and ptsG gene manX acid production ability deletion
  • E. coli C mutant strains which are gene deleted
  • an E. coli C mutant strain lacking agaW , agaE , agaF and agaA is provided.
  • the E. coli C variant strain is Escherichia coli HK1017 strain described in the embodiment of the present invention, deposited with accession number KCTC13266BP.
  • the present invention also ptsI gene is provided an adaptive evolution (adaptive evolution) as a strain obtained by the culture method, it enhanced E. coli K-12 mutant strain further the exuR gene ability deletions, succinic acid production in E. coli K-12 strain deleted .
  • the adaptive evolution culture method may be cultured under anaerobic conditions in a medium containing kanamycin, but is not limited thereto.
  • the E. coli K-12 variant strain is Escherichia coli HK950 strain described in the embodiment of the present invention, deposited with accession number KCTC13264BP.
  • the present invention provides an E. coli K-12 mutant strain, in which exuR gene is deleted, in addition to the E. coli K-12 strain, which is deleted from ptsI gene, which has improved succinic acid production capacity.
  • Glucose and town North specific leader transport system genes ptsG and manX was E. coli K-12 BW25113 strain, leader transport system complex in which Escherichia coli K-12 BW25113 strain and that E. coli C strain deleted for ptsG deleting a gene ptsI constituting the deletion per
  • (KCTC2571) is cultured under anaerobic conditions, the growth rate of the strain is reduced. Under the condition that the strain growth rate is lowered, the culture solution is plated on a solid medium at the time when 50 mM of all the glucose added by anaerobic culture is continuously consumed to obtain progeny strain.
  • the progeny strains thus obtained were again anaerobicly cultured under the same conditions, the growth rate of the strain was restored, and mutant strains with increased production capacity of succinic acid could be selected.
  • Escherichia coli K-12 BW25113 ⁇ ptsG ⁇ manX The strain produced no lactic acid from 50 mM glucose and succinic acid produced 31 mM, but it took 84 hours to consume all the glucose. On the contrary, the adapted progeny strains consumed all of the glucose within 36 hours and grew faster than the parent strains. Also, the production of formic acid and ethanol was significantly decreased, and lactic acid, a byproduct, was not produced. The yield was further improved and found to be 36.7-40.3 mM. In addition, E.
  • Genomes of the selected mutant progeny strains were analyzed using next-generation sequencing technology to compare and analyze the genome sequences of the parent strains to identify the target genes for which the mutations were generated.E. Coli K-12 BW25113 ⁇ ptsG If ⁇ is manX adaptive evolution was confirmed that a mutant gene is created on exuR, it was confirmed that the mutant gene is created on exuR even when the E. coli K-12 ⁇ BW25113 ptsI is adaptive evolution. In addition, E. coli C (KCTC2571) ⁇ ptsG Adaptive Evolution from Strains Mutations in the agaR gene were identified. Complementation tests show that exuR and agaR mutations can be found in E.
  • exuR and agaR It was confirmed by qRT-PCR that the amount of mRNA of the genes exuT , agaV , agaB genes which are inhibited by the transcription regulators increased due to mutation of the ExuR and AgaR transcription regulators encoded by the gene. Thus it was when the transport system, such as a gene per ptsG, manX, ptsI deletion through a transport protein or Aga glucose transport protein complex per ExuT confirmed that the glucose into the cells can be transported.
  • the transport system such as a gene per ptsG, manX, ptsI deletion through a transport protein or Aga glucose transport protein complex per ExuT confirmed that the glucose into the cells can be transported.
  • the present invention comprises the steps of culturing the variant strain; And it provides a method for producing succinic acid comprising the step of obtaining succinic acid from the culture.
  • the culturing may be performed under anaerobic conditions.
  • the present invention provides a mutant microorganism having improved succinic acid production ability using evolutionary engineering and a succinic acid production method using the same.
  • the NCBI Gene ID of the gene having the mutation is as follows. manX (Gene ID: 946334), ptsG (Gene ID: 945651), exuR (Gene ID: 947602), agaR (Gene ID: 947636), agaW (Gene ID: 947647), agaE (Gene ID: 916505), agaF (Gene ID: 916152), agaA (Gene ID: 947646), and ptsI (Gene ID: 946879).
  • the newly identified “ExuT” sugar transport protein and “Aga” sugar transport protein complex using adaptive evolution may be the target of new metabolic engineering.
  • it can be used to increase the production of succinic acid by introducing into various existing E. coli strains that have been developed as succinic acid producing strains.
  • the glucose transport system of the present invention may be used to increase succinic acid production in succinic acid-producing ruminants.
  • the term 'deletion' is a concept encompassing a part or whole base of the gene, mutating, substituting or deleting, or introducing some base so that the gene is not expressed or does not exhibit enzymatic activity even when expressed. It includes everything that blocks the biosynthetic pathways involved in the enzymes of the gene.
  • the parent strain in the present invention is a strain in which the growth rate of the microorganism is reduced or does not produce the desired fermentation product well, both wild-type or specific gene mutants.
  • the progeny strain had a mutation not possessed in the genome of the parent strain, so that the growth rate of the strain was recovered faster than that of the parent strain, and the desired fermentation product had a high yield or high productivity. It is a strain produced by.
  • the adaptive evolution is a process of obtaining the offspring strains which have been grown at a rapid growth rate by culturing the parent strains with low growth rate until the carbon source such as glucose is depleted, and then spreading them on a solid medium.
  • the medium used for the adaptive evolution is not particularly limited, but the glucose concentration is preferably 8-20 g / L, most preferably 9 g / L as the initial carbon source, and the culture is 35-45. It can be carried out under a temperature of °C, preferably 35 ⁇ 39 °C, most preferably 37 °C, and initial pH conditions of 6.0 ⁇ 7.5, preferably 6.3 ⁇ 6.7, most preferably 6.5.
  • the culture is preferably carried out under anaerobic conditions, anaerobic conditions can be formed by supplying nitrogen to the head space of the incubator, by adding Na 2 S to remove dissolved oxygen in the liquid medium.
  • the incubator is not particularly limited but may exemplify a serum bottle.
  • P1 lysate for P1 transduction was performed as follows. First, ptsG related to sugar transport system And mutant E. coli strain in ptsI gene is replaced with the kanamycin (kanamycin) resistance gene (E. coli ⁇ ptsG :: KmR, E.
  • kanamycin is 25 ⁇ g each strain Smear LB solid medium containing / ml, incubated single colonies in 25 ml LB liquid medium containing 0.01 M MgSO 4 , 0.005 M CaCl 2 and incubated at 37 °C until OD 600nm becomes 0.4, To inoculate 250 ⁇ l of P1 bacteriophage to dissolve each mutant strain, the cells were further incubated at 37 ° C. for 4 hours.
  • K-12 BW25113 (CGSC7636, The Coli Genetic Stock Center, Yale University) wild type strains to infect the prepared P1 lysate to induce gene deletion were cultured by inoculating LB liquid medium containing 0.01 M MgSO 4 , 0.005 M CaCl 2 . centrifuged at 5000 rpm after which the medium was removed, and the precipitate was suspended in the cell (cell pellets) of 0.01 M MgSO 4, 0.005 1 ml LB broth containing the M CaCl 2. After mixing 100 ⁇ l each of the P1 lysate prepared above and the wild type strain to introduce the gene deletion, incubate at 37 ° C.
  • E. coli K-12 BW25113 strains were prepared as follows. first, A single deletion mutant strain in which each manX gene was substituted with a kanamycin resistance gene was obtained from the KEIO collection. PK20 (CGSC7629, The Coli Genetic Stock Center, Yale University) was transformed into the HK620 strain prepared by the above P1 transduction, and plated on 50 ⁇ g / mL of ampicillin (ampicillin) in an LB solid medium. Homologous recombination of the sequences was induced to construct an HK812 strain (E.
  • strain HK812 has a ptsG gene deletion but kanamycin resistance does not possess.
  • manX deletion mutant strain ( ⁇ manX :: KmR) to infect a P1 lysate prepared by a donor strain by P1 transduction of the E. coli K-12 performed BW25113 ⁇ ⁇ ptsG manX :: KmR
  • a strain was produced and named parent strain HK907.
  • Escherichia coli C (KCTC2571, Korean Collection for Type Cultures) strain which deleted glucose specific ptsG was prepared as follows. To the ptsG single deletion mutation in the E. coli C strain wild-type strain to accommodate the donor strain HK864 strain was produced by performing the P1 transduction As a result, a parent strain. By the way, in the case of E. coli strain C, manX , a sugar-specific gene for sugar transport, It is already inactivated due to IS insertion into the gene.
  • the prepared parent strains HK907, HK898, and HK864 were plated on LB solid medium containing kanamycin at 25 ⁇ g / mL, respectively, and inoculated with 5 mL of LB liquid medium, and grown at 37 ° C. for 12 hours.
  • Medium to the fermentation culture medium (glucose, 9g (final 50 mM ); yeast extract, 5g; NaHCO 3, 10g; NaH 2 PO 4 ⁇ H 2 O, 8.5g; K 2 HPO 4, 15.5g per liter (pH7.0 1) Inoculate 1 ml into a 125 ml serum bottle containing 100 ml, add 1 ml of Na 2 S, seal it, and fill the upper layer with nitrogen gas to remove oxygen from the serum bottle and incubate at 37 ° C. Strain growth and fermentation products were analyzed every 6 hours. For growth and fermentation analysis of strains, 1 ml of each strain was taken, 100 ul was diluted 1:10 in PBS, and the OD 600nm value was measured to analyze the growth of the strain.
  • the remaining culture was 10 minutes at 12000 rpm. Centrifuge and filter the culture using a 0.2 um nylon filter and use this filtrate for HPLC analysis. Glucose, succinic acid, lactic acid, formic acid, acetic acid and ethanol were analyzed using an Aminex HPX-87H column (Bio-rad) and 0.1 NH 2 SO 4 solution as the mobile phase.
  • Figure 1 shows the growth and fermentation yield of the parent strain under anaerobic conditions of HK907, HK898 and HK864.
  • the growth of the strain was observed after the HK907 strain had a delay period of about 48 hours, and it took 84 hours to consume all 50 mM glucose, wherein the succinic acid production was 31.7 mM, and the HK898 strain was about After 54 hours of delay, the growth of the strain was observed and it took 96 hours to consume all 50 mM glucose, with succinic acid production of 53.5 mM.
  • the growth of the strain was observed after the HK864 strain had a delay period of about 36 hours, it took 66 hours to consume all 50 mM glucose, the succinic acid production was 22.7 mM (Fig. 1).
  • Single culture colonies of progeny strains are obtained by spreading the culture medium of the parent strains that have consumed all of the glucose of Example 1 onto LB solid medium. Single progeny colonies of each progeny strain were precultured in the same manner as the parent strain, and were anaerobicly cultured in fermentation broth. As a result of the culture, it was confirmed that all of the added glucose was consumed by selecting strains having no delay and growth rate among progeny strains (FIG. 2).
  • HK907 progeny strains (HK953, HK954, HK955, HK956, HK957, HK958) were selected and consumed all of the glucose within 36 hours of anaerobic culture. . Therefore, compared to the parent strain HK907, the incubation time of the progeny strains was reduced by 48 hours, the production of succinic acid was increased by 5 ⁇ 8.6 mM, and the productivity of succinic acid was also increased.
  • HK898 progeny strains (HK947, HK948, HK949, HK950, HK951, HK952) were selected, consumed all the glucose within 48 hours of anaerobic culture, and succinic acid production was found to be 51.9-54.4 mM (Table 1). 2). Therefore, compared to the parent strain HK898, the incubation time of the progeny strains was shortened by 48 hours, the production of succinic acid is almost no difference, but succinic acid productivity was increased.
  • progeny strains of HK864 were selected, and these progeny strains consumed all the glucose at 12 hours, and the production of succinic acid was 18.6 ⁇ 20.3 mM (Table 3). ). Therefore, compared to the parent strain HK864, the growth time of the progeny strains was shortened by 54 hours. Thus, the production of succinic acid per hour, that is, the productivity (productivity) increased by about 4.6-5 times.
  • Mutant target genes were identified through genome analysis of progeny strains with increased growth and increased succinic acid production.
  • Single colonies of parent strains (HK907, HK878, HK864) and progeny strains (HK956, HK949, HK878, HK881) to be used for genome analysis were inoculated in 5 ml LB liquid medium, incubated at 37 ° C for 16 hours, and 1 ml of the culture was 3000 rpm, The supernatant was removed by centrifugation for 10 minutes and the cells were recovered.
  • Cells were isolated from strain genomic DNA using Wizard Genomic DNA purification kit (Promega).
  • HiSeq2000 a large-capacity genome detoxification instrument
  • the library production was in compliance with Illumina's standard method (A260 / 280 ratio of Sample DNA over 1.8, minimum concentration over 100 ng / ⁇ l, total amount over 5 ⁇ g)
  • Pretreatment of the sequence data and assembly of sequence fragments were performed to compare and analyze the genome sequences of the parent strain and the genome sequences of the progeny strain to identify newly acquired mutations in the progeny strain.
  • exuR which encodes the transcriptional regulator ExuR protein
  • HK878 a progeny strain of HK864, 256 bp sequences (C239 to C494) of the agaR gene encoding the N-Acetylgalactosamine inhibitor were repeated.
  • HK881 agaR Mutations in which the 469th base of the gene was substituted for G to A were identified.
  • agaR gene regions of HK879 and HK880, which are different progeny strains, were amplified by PCR and analyzed by sequencing method, it was confirmed that different base substitution mutations were introduced (Table 6).
  • ExuR and agaR to determine if the identified mutant traits affect the growth recovery and succinic acid production of the strain compared to the parent strain A single gene deletion was intended to be introduced into the parent strain.
  • HK907 strain, a parent strain of K-12 BW25113, and HK864 strain, a strain of C (KCTC2571) strain were used to remove the kanamycin antibiotic resistance gene using the pCP20 plasmid as in Example 1 above.
  • HK918 and HK902 strains were produced, respectively.
  • P1 lysate was prepared by infecting HK918 strain with exuR single gene deletion trait, and P1 transduction was performed.
  • ptsG manX And an HK966 strain with exuR gene deletion mutations.
  • HK918 strain ptsG, manX agaR deletion and gene deletion and aga An HK923 strain into which the gene group constituting the operon ( agaWEFA ) was introduced was prepared.
  • aga The gene group constituting the operon ( agaWEFA ) is deleted in the K-12 BW25113 strain, and thus the agaR gene, which is a gene encoding a transcriptional regulator, is deleted.
  • a gene group constituting the aga operon was introduced into the K-12 BW25113 strain.
  • the K-12 BW25113 strain in which the agaR gene region was substituted with kanamycin was obtained from the KEIO collection, and PCR amplified to include the agaR :: KmR region, thereby obtaining a PCR product, and containing the ⁇ gene of lambda phage, thus homologous linear DNA.
  • P1 bacteriophage was infected with HK909 strain to prepare P1 lysate, which was then introduced into the HK918 strain, which is a receiving strain of K-12 BW25113, to prepare a HK923 strain.
  • the resulting HK966 and HK923 strains were cultured under anaerobic conditions to analyze the growth of the strain and the organic acid of the final fermentation product.
  • the presence or absence of aga operon gene group is represented by aga + gam + or aga-gam- respectively.
  • the HK966 strain took 36 hours to consume 50 mM glucose, remained 2.3 mM of residual sugar, and produced 33.0 mM of succinic acid without lactic acid. Thus, succinic acid production increased 1.3 mM and productivity increased 2.4 times compared to HK904 parent strain.
  • HK919 strains with ptsG and agaR deletion mutations in the E. coli C (KCTC2571) strain background were prepared as above, and HK1014 strains with ptsG and exuR deletion mutations prepared P1 lysate with exuR single gene deletion trait and were the recipient strains. It was obtained by infection with HK902 and P1 transduction.
  • the strains HK1017 and HK1015 deleted ptsG , agaR and exuR were prepared as follows.
  • P1 lysate with exuR single gene deletion trait was prepared and ptsG , agaR and exuR were carried out by H1 and B1 strains containing HK976 strain resistant to kanamycin antibiotic resistance using pCP20 plasmid in HK919.
  • a (aga + gam +) HK1015 strain was produced having agaWEFA , a gene deleted and constituting an aga operon.
  • exuR with a P1 lysate with a single gene-deficient trait at HK912 using pCP20 plasmid by the HK1016 strain to remove the kanamycin antibiotic resistance gene into a receiving strain carried the P1 transduction with a gene agaWEFA constituting aga operon is deleted ( aga-gam-) HK1017 strain was prepared.
  • HK1015 and HK1017 have different aga operons, and HK1017 strain is additionally added to transport glucose to the sugar transport protein ExuT due to the deletion of the transcriptional regulator ExuR. aga operon fruited .
  • These strains were cultured under anaerobic conditions to analyze the growth of the strain and the organic acid of the final fermentation product. The results are shown in Table 8.
  • the HK1014 strain, ptsG and exuR multiple deletion mutant Escherichia coli strain C took 24 hours to consume 50 mM glucose, did not produce lactic acid, and produced 34.4 mM of succinic acid. Succinic acid productivity was significantly improved to 1.43 (mM / h). Also The HK919 strain, ptsG and agaR plural deletion mutant Escherichia coli strains, took 9 hours to consume all 50 mM glucose. When lactic acid was produced at 2.2 mM, succinic acid was produced at 16.8 mM. The amount of succinic acid produced was not large, but the growth rate was very fast, and it was confirmed that the productivity of succinic acid increased significantly to 1.87 (mM / h).
  • the HK1017 strain which lacks the ptsG , agaR , exuR multiple deletions, and the aga operon gene family, takes 36 hours to consume all the glucose, but does not produce lactic acid but produces 42 mM succinic acid with a succinic acid productivity of 1.16 (mM / h It was confirmed that).
  • ExuR transcription regulators are known to inhibit the expression of exuT , a gene encoding ExuT, a transport protein of aldohexuronates such as D-galacturonate and D-glucuronate (Mata-Gilsinger, M., Ritzenthaler, P., Mol Gen Genet, 1983).
  • AgaR transcription regulators are also known to inhibit the expression of the aga gene family ( agaZVWEFA ), which encodes proteins involved in the transport of N-acetylgalactosamine and D-galactosamine (Ray, WK, Larson, TJ, Mol Microbiol, 2004). .
  • the Escherichia coli wild type strain (BW25113) and ptsG, manX QRT-PCR was performed as follows to compare the expression levels of exuT genes of the parent strain (HK907) and the adapted progeny strain (HK953).
  • the strain BW25113 was 3 hours old, and the parent strain HK907 took 6 hours of delay and 54 hours of onset of growth, and the strain of HK953, a progeny strain, took 3 hours of RNA protection bacterial reagent (Qiagen). After mixing with the solution, total RNA was purified using RNAeasy Mini kit (Qiagen) (FIG. 3). Purified total RNA was measured using NanoDrop, and each primer for qRT-PCR was determined using Roche's Universal Library Assay Design Center (https://lifescience.roche.com). exuT gene was specifically produced (Table 9).
  • CDNA was synthesized using 5 ng of total RNA (50 ° C., 40 minutes), and cDNA amplification (95 ° C., 20 sec; 60 ° C., 1 min; 40 cycles) was performed. Data obtained through qRT-PCR were analyzed using the LightCycler 96 (Roche Diagnostics, Mannheim, Germany) program, and the relative expression levels compared to the expression level of 16S ribosomal RNA were analyzed.
  • C strain E. coli wild type strain (KCTC2571) and ptsG QRT-PCR was performed to compare the expression levels of the agaV and agaB genes of the parent strain (HK864) and the adapted progeny strain (HK878).
  • KCTC2571 strain was 3 hours, the parent strain HK864 strain was delayed at 12 hours and growth started at 54 hours, and progeny strain HK878 strain was taken at 3 hours and RNA protect bacterial reagent (Qiagen) After mixing with the solution, total RNA was purified using RNAeasy Mini kit (Qiagen). qRT-PCR was performed as described above, and the primers for qRT-PCR were specifically constructed for agaV and agaB genes (Table 9). The expression levels of agaV and agaB genes in the wild-type strain and the parent strain HK864 were found to be almost the same, and at the 54 hours when the growth of the parent strain was confirmed, it was found to increase about 3.3 times compared to the wild-type strain.
  • the progeny strain HK878 was found to increase by 3.8 times. Therefore, it was confirmed that the expression of agaV , agaB gene is increased due to the mutation of the agaR gene according to the adaptive evolution (Fig. 4). Also aga Due to the increased expression of the gene group, it was confirmed that glucose can be transported into the cell through the Aga transport protein.

Abstract

The present invention relates to a mutant microorganism having enhanced succinic acid production capacity and a succinic acid production method using the same. The present invention has the effect of obtaining a mutant microorganism that decreases in the production of fermented products such as lactic acid, ethanol, etc., but produces succinic acid at a high concentration due to the mutation of a transcription regulator factor associated with microbial sugar transport as a result of adaptive evolution upon deletion of a gene involved in the sugar transport in an anaerobic condition and of providing a method in which the obtained mutant microorganism is cultured to produce succinic acid at high yield or with high productivity.

Description

숙신산 생산능이 향상된 변이 미생물 및 이를 이용한 숙신산 생산방법Mutant microorganism with improved succinic acid production capacity and succinic acid production method using the same
본 발명은 숙신산 고생산능을 가지는 변이 미생물을 제작하는 방법에 관한 것으로, 더욱 상세하게는 당수송에 관여하는 유전자들이 결실된 미생물을 혐기조건에서 적응진화시켜 성장속도가 빠른 변이 균주를 선별하여, 변이균주 또는 변이균주에서 확인된 돌연변이를 인위적으로 도입한 균주를 혐기조건에서 배양하여 발효산물인 숙신산을 고수율 또는 고생산성으로 제조하는 미생물 진화공학 방법에 관한 것이다.The present invention relates to a method for producing a mutant microorganism having high succinic acid production capacity, and more particularly, by selecting and evolving a microorganism lacking genes involved in sugar transport under anaerobic conditions, selecting a fast-growing mutant strain. It relates to a microbial evolution engineering method for producing a fermentation product succinic acid in high yield or high productivity by culturing the strain artificially introduced strains identified in strains or mutant strains under anaerobic conditions.
숙신산(succinic acid)은 4개의 탄소로 이루어진 다이카르복실산으로 의약용, 식품용, 화장품 및 그 외 산업에서 사용되는 화학제품의 전구체로서 널리 사용되는 산업적, 경제적 이용 가치가 매우 높은 유기산이다. 특히, C4 계열 화학물질인 1,4-부탄디올(1,4-butanediol; BDO), 테트라하이드로퓨란(tetrahydrofuran; THF), 감마-뷰티로락톤(gamma-butyrolactone; GBL), 2-피롤리돈(2-pyrrolidone) 등으로 전환될 수 있으며, 생분해성 고분자(biodegradable polymer)의 일종인 폴리뷰티렌 석시네이트(polybutyrene succinate; PBS) 및 다양한 폴리에스터(polyesters) 생산을 위한 원료물질로도 사용이 가능하여 산업적 응용가능성이 크다.Succinic acid is a four-carbon dicarboxylic acid, an organic acid with high industrial and economic value, widely used as a precursor for chemicals used in medicine, food, cosmetics and other industries. Specifically, 1,4-butanediol (BDO), tetrahydrofuran (THF), gamma-butyrolactone (GBL), 2-pyrrolidone (C4 series chemicals) 2-pyrrolidone) and can be used as a raw material for the production of polybutyrene succinate (PBS) and various polyesters, a kind of biodegradable polymer. Large industrial applicability.
현재 상업적으로 사용되고 있는 대부분의 숙신산(succinic acid)은 석유화학공정을 통하여 생산된 말레익 안하이드라이드(maleic anhydride)를 액상 수소화(liquid phase hydrogenation) 반응에 의하여 석시닉 안하이드라이드(succinic anhydride)로 전환시키고, 이를 다시 수화(hydration) 반응을 통해 숙신산(succinic acid)으로 전환하여 생산하고 있다. Most of succinic acid currently used commercially is converted to maleic anhydride produced by petrochemical process into succinic anhydride by liquid phase hydrogenation reaction. Converted to succinic acid through a hydration reaction and produced.
자연계에서 숙신산은 시트르산회로 (TCA cycle)의 중간물질로서, 또한 혐기발효(anaerobic fermentation)의 최종 대사산물(final metabolic product)로 생성된다. 따라서 거의 모든 미생물로부터, 식물 및 동물세포까지 숙신산을 생산하는데, 특히 Aspergillus 계열의 곰팡이와 Actinobacillus, Mannheimia와 같은 반추위(Rumen)에서 분리된 세균에서 상대적으로 과량의 숙신산을 생산하는 것으로 알려져 있으며, 현재까지 발효를 통한 숙신산 생산에는 반추미생물의 일종인 Actinobacillus, AnaerobiospirillumMannheimia 균주를 이용한 숙신산 생산 연구가 많이 진행되어 왔다. 미국의 Michigan Biotechnology Institute (MBI) 연구진은 Actinobacillus succinogenes 130Z 균주 (ATCC No. 55618)를 발굴하여 숙신산 생산공정을 개발하였으며, 고전적인 화학적 돌연변이 방법을 이용하여 Anaerobiospirillum succiniciproducens의 다양한 변이균주들을 개발하여 이를 숙신산 생산 및 정제공정 개발에 이용하였다. 또한, 카이스트의 이상엽 교수팀은 숙신산 생산능력을 보이는 루멘박테리아인 M. succiniciproducens MBEL55E (KCTC0769BP) 균주를 동정하고 게놈서열 및 대사특성을 발표하였으며, 숙신산 생산과 경쟁경로에 있는 젖산과 개미산의 생성을 억제하기 위하여 젖산 탈수소화효소 유전자(ldhA)와 피루브산-개미산 분해효소 유전자(pfl)를 결실 시킨 변이균주인 M. succiniciproducens LPK (KCTC10558BP)를 제작하였으며, 더 나아가 초산의 생성을 저해하기 위해 상기 변이균주 M. succiniciproducens LPK에서 포스포트랜스아세틸화효소 유전자(pta)와 아세트산 키나제 유전자(ackA)를 결실시킨 변이균주 M. succiniciproducens LPK7 (KCTC10626BP)을 제작하여 이들을 혐기조건에서 배양하여 숙신산을 제조한 바 있다. 또한, 상기 연구에서 부산물의 생성은 억제하였으나 균주의 성장속도가 현저히 낮아지는 문제가 있었으나, 후속연구를 통하여 M. succiniciproducens MBEL55E 균주에서 피루브산-개미산 분해 효소 유전자(pfl)는 결실시키지 않고, 젖산 탈수소화효소 유전자(ldhA), 포스포트랜스아세틸화효소 유전자(pta) 및 아세트산 키나제 유전자(ackA)는 결실시킨 변이균주 M. succiniciproducens PALK (KCTC10973BP)를 제작한 다음, 상기 균주를 혐기적 조건에서 글루코스와 글리세롤을 탄소원으로 사용하여 발효시켜 미생물의 성장속도 저하를 최소화 하고, 동시에 피루브산을 포함한 다양한 부산물의 생성을 완전히 차단하여 높은 수율로 숙신산을 제조할 수 있는 변이 미생물 및 발효방법을 개발하였다. In nature, succinic acid is produced as an intermediate in the TCA cycle and also as a final metabolic product of anaerobic fermentation. Thus, succinic acid is produced from almost all microorganisms, from plants and animal cells, and in particular, it is known to produce a relatively large amount of succinic acid from bacteria isolated from rumens such as Aspergillus family of fungi and Actinobacillus and Mannheimia . Succinic acid production through fermentation includes actinobacillus , Anaerobiospirillum and Mannheimia Succinic acid production using the strain has been much research. American Michigan Biotechnology Institute (MBI) researchers Actinobacillus succinogenes A 130Z strain (ATCC No. 55618) was discovered to develop a succinic acid production process, and various mutant strains of Anaerobiospirillum succiniciproducens were developed using the classical chemical mutation method and used for the production and purification of succinic acid. In addition, KAIST's Sang-Yeop and his team identified the M. succiniciproducens MBEL55E (KCTC0769BP) strain, a lumen bacterium that exhibits succinic acid production, and published genomic sequences and metabolic characteristics. M. succiniciproducens LPK (KCTC10558BP), a mutant strain from which the lactic acid dehydrogenase gene ( ldhA ) and the pyruvate-formatease gene ( pfl ) was deleted, was further produced. Furthermore, the mutant strain M was inhibited to inhibit the production of acetic acid. . succiniciproducens Mutant strain M. succiniciproducens LPK7 (KCTC10626BP), in which phosphotransacetylacetylase gene ( pta ) and acetic acid kinase gene ( ackA ) were deleted from LPK, was produced and cultured in anaerobic conditions to prepare succinic acid. In addition, although the production of the by-products was suppressed in the above study, there was a problem that the growth rate of the strain was significantly lowered. However, through the subsequent study, the pyruvate-formic acid degrading enzyme gene ( pfl ) was not deleted in the M. succiniciproducens MBEL55E strain, and lactate dehydrogenation was performed. The enzyme gene ( ldhA ), phosphotransacetylacetylase gene ( pta ) and acetic acid kinase gene ( ackA ) produced a mutant strain M. succiniciproducens PALK (KCTC10973BP) that was deleted, and then the strain was subjected to glucose and glycerol in anaerobic conditions. Fermented by using as a carbon source to minimize the growth rate of microorganisms and at the same time developed a mutant microorganism and fermentation method that can produce succinic acid in high yield by completely blocking the production of various by-products including pyruvic acid.
재조합 대장균을 이용한 숙신산 생산 연구도 활발히 진행되어왔는데, 미국 시카고 대학 연구팀이 대장균의 젖산(lactic acid) 및 개미산(formic acid) 생산에 관여하는 유전자들(ldhApflB)을 제거함과 동시에 글루코스 전달시스템 유전자(ptsG)를 조작한 대장균 변이균주인 AFP111 (ATCC No. 202021)을 제작하여 숙신산 생산 증가를 시도하였다. 또한 미국 조지아 대학 연구팀은 Rhizobium etli 균주의 피루브산 카르복실화 유전자(pyc)를 상기의 대장균 AFP111 균주에 발현시킴으로써 AFP111/pTrc99A-pyc 균주를 제작하고, 이를 이용하여 숙신산을 생산하였다.Research on the production of succinic acid using recombinant Escherichia coli has been actively conducted, and a team of researchers from the University of Chicago, USA, removes genes ( ldhA and pflB ) that are involved in the production of lactic and formic acid in Escherichia coli, and at the same time, a glucose delivery system gene. to produce a (ptsG) Escherichia coli mutant strain AFP111 (ATCC No. 202021) was attempted to operate the increased acid production. Rhizobium, a research team at the University of Georgia making the AFP111 / pTrc99A-pyc strain by expressing pyruvate carboxylation gene (pyc) of etli in E. coli AFP111 strain of the strain, and by using this produced the acid.
상기와 같이, 숙신산을 고수율 또는 고생산성으로 제조하는 미생물에 대한 관심이 집중되고 있으며, 이러한 미생물에 대한 진화공학적 생산방법에 대해서도 연구가 필요하다.As described above, attention is focused on microorganisms for producing succinic acid in high yield or high productivity, and research on the evolutionary engineering method for such microorganisms is required.
본 발명의 목적은 당수송계와 관련된 유전자들이 결실된 돌연변이 미생물 균주를 적응진화시켜서 빠른 성장속도를 보이고 숙신산 생산능이 향상된 적응진화 돌연변이 균주를 선별하고, 돌연변이 타겟 유전자를 확인하는 방법을 제공하는데 있다. 또한 본 발명의 다른 목적은 상기 적응진화된 돌연변이 미생물 또는 돌연변이 타겟 유전자를 인위적으로 도입한 미생물 균주를 혐기배양하여 숙신산을 고수율 또는 고생산성으로 제조하는 방법을 제공하는 데에 있다.An object of the present invention is to provide a method for selecting a mutant microorganism strain showing a rapid growth rate and improved succinic acid production capacity by adaptively evolving a mutant microorganism strains genes related to the sugar transport system, and to identify a mutant target gene. It is another object of the present invention to provide a method for producing succinic acid in high yield or high productivity by anaerobic culture of a microorganism strain into which the adapted mutant microorganism or a mutant target gene is artificially introduced.
상기 과제의 해결을 위하여, 본 발명은 숙신산 생산능이 향상된, manXptsG 유전자가 결실된 대장균 K-12 균주에 추가적으로 exuR 또는 agaR 유전자가 결실되거나, exuRagaR 유전자가 모두 결실된 대장균 K-12 변이 균주를 제공한다.In order to solve the above problems, the invention is succinic acid producing ability improved, manX and ptsG gene is the or a further exuR or agaR gene deletion with the deletions of E. coli K-12 strain, exuR and agaR genes are both deleted E. coli K-12 mutant Provide strains.
또한, 본 발명은 숙신산 생산능이 향상된, manXptsG 유전자가 결실된 대장균 C 균주에 추가적으로 exuR 또는 agaR 유전자가 결실되거나, exuRagaR 유전자가 모두 결실된 대장균 C 변이 균주를 제공한다.The present invention also provides a succinic acid producing ability improved, in addition to the E. coli C strain manX and ptsG gene deletion or exuR agaR gene is a deletion or, exuR and agaR genes are both deleted Escherichia coli mutant strain C.
또한, 본 발명은 상기 대장균 C 변이 균주에 추가적으로 agaW, agaE, agaFagaA가 결실된, 숙신산 생산능이 향상된 대장균 C 변이 균주를 제공한다.In addition, the present invention provides an E. coli C mutant strain having improved succinic acid production ability, in which agaW , agaE , agaF and agaA are deleted in addition to the E. coli C variant strain.
또한, 본 발명은 ptsI 유전자가 결실된 대장균 K-12 균주의 적응 진화(adaptive evolution) 배양 방법을 통해 얻은 균주로서, exuR 유전자가 추가적으로 결실된, 숙신산 생산능이 향상된 대장균 K-12 변이 균주를 제공한다.The present invention also ptsI gene is provided an adaptive evolution (adaptive evolution) as a strain obtained by the culture method, it enhanced E. coli K-12 mutant strain further the exuR gene ability deletions, succinic acid production in E. coli K-12 strain deleted .
또한, 본 발명은 숙신산 생산능이 향상된, ptsI 유전자가 결실된 대장균 K-12 BW25113 균주에 추가적으로 exuR 유전자가 결실된 대장균 K-12 변이 균주를 제공한다.The present invention also provides a succinic acid producing ability improved, ptsI gene is additionally exuR gene is an E. coli K-12 mutant strain deleted in a deletion of E. coli K-12 strain BW25113.
또한, 본 발명은 상기 변이 균주들을 배양하여, 상기 배양액으로부터 숙신산을 수득하는 단계를 포함하는 숙신산 생산방법을 제공한다.In addition, the present invention provides a method for producing succinic acid comprising the step of culturing the mutant strains to obtain succinic acid from the culture.
본 발명은 숙신산 생산능이 향상된 변이 미생물 및 이를 이용한 숙신산 생산방법에 관한 것으로서, 혐기조건에서 미생물의 당수송에 관여하는 유전자가 결실되었을 때, 적응진화에 의해 생성된 당수송 관련 전사조절인자의 돌연변이로 인하여 젖산, 에탄올 등의 발효산물의 생성은 감소하고, 숙신산을 고농도로 생산하는 특징을 가지는 변이 미생물을 얻고, 상기 변이 미생물을 배양하여 고수율 또는 고생산성으로 숙신산을 제조하는 방법을 제공하는 효과가 있다.The present invention relates to a mutant microorganism having improved succinic acid production capacity and a succinic acid production method using the same, wherein when a gene involved in sugar transport of a microorganism is deleted in anaerobic conditions, it is a mutation of a sugar transport-related transcriptional regulator produced by adaptive evolution. Due to the production of fermentation products, such as lactic acid, ethanol is reduced, obtain a mutant microorganism having the characteristic of producing succinic acid at a high concentration, and by culturing the mutant microorganism to provide a method for producing succinic acid in high yield or high productivity have.
도 1은 모균주인 HK907, HK898 및 HK864 균주의 성장과 발효산물의 변화를 시간에 따라서 나타낸 것이다.Figure 1 shows the growth and fermentation products of the parent strains HK907, HK898 and HK864 strain over time.
도 2는 HK907, HK898 및 HK864 균주가 적응진화된 자손균주들의 성장곡선을 나타낸 것이다.2 shows growth curves of progeny strains to which HK907, HK898 and HK864 strains have been adapted.
도 3은 K-12 균주의 야생형 균주(BW25113), 모균주(HK907) 및 적응진화된 자손균주(HK953)의 exuT 유전자의 mRNA 발현량을 나타낸 것이다.Figure 3 shows the mRNA expression level of the exuT gene of wild type strain (BW25113), parent strain (HK907) and adapted progeny strain (HK953) of K-12 strain.
도 4는 C 균주의 야생형 균주(KCTC2571), 모균주(HK864) 및 적응진화된 자손균주(HK878)의 exuT 유전자의 mRNA 발현량을 나타낸 것이다.Figure 4 shows the mRNA expression level of the exuT gene of wild type strain (KCTC2571), parent strain (HK864) and adapted progeny strain (HK878) of C strain.
본 발명자들은 2013년 Metabolic Engineering 誌에 발표한 선행논문에서, 대장균에서 유전체 수준의 수백개의 유전자의 결실 돌연변이 균주를 제작하고, 혐기발효를 통한 발효산물의 생산패턴에 대한 유전체 수준의 연구결과를 얻어내었다. 이 연구에서 특히, 포도당 특이적인 당수송계에 관련된 ptsG 유전자 결실 돌연변이 균주의 경우에서 균주의 성장이 야생형 균주에 비하여 감소하고 잔당이 남아 있음에도 불구하고, 숙신산 생산이 증가한 것을 확인하고 이를 보고한 바 있다(Kim, H. J., et al., Metab Eng, 2013). In the previous paper published in Metabolic Engineering 년 in 2013, the present inventors produced mutant strains of deletions of hundreds of genes at the genome level in Escherichia coli, and obtained the results of genome-level studies on the production patterns of fermentation products through anaerobic fermentation. . In this study, especially in the case of ptsG gene deletion mutant strains related to the glucose-specific sugar transport system, the growth of succinic acid production was confirmed and reported, although the growth of the strain was reduced compared to the wild-type strain and residuals remained. Kim, HJ, et al., Metab Eng, 2013).
상기의 연구에서는 ptsG 유전자 결실균주를 24시간 동안만 배양하였으므로, 첨가해준 포도당을 모두 소모하지 못하고, 야생형 균주에 비하여 균주의 성장이 잘 되지 않는 문제가 있었다. 따라서 본 발명에서는 첨가해준 포도당을 모두 소모할 때까지 배양하고, 이로부터 적응진화된 자손균주를 얻고 혐기배양을 통해서 성장속도가 회복되고 숙신산 생산능이 향상된 균주를 선별하였다. 또한, 모균주와 자손균주의 유전체 염기서열 분석을 통해서 돌연변이가 생성된 유전자를 확인하였고, 확인된 유전자의 돌연변이가 숙신산 생산 증가에 영향을 주는지를 유전자 상보성 테스트(complementation test)로 확인하였다. 그리고, 적응진화된 자손균주를 혹은 자손균주에서 확인된 돌연변이를 인위적으로 도입한 균주를 혐기조건에서 배양하여 발효산물인 숙신산을 고수율 또는 고생산성으로 제조하는 미생물 진화공학 방법을 완성하였다. In the above study, since the ptsG gene deletion strain was cultured only for 24 hours, it did not consume all the added glucose and there was a problem that the growth of the strain was not as good as that of the wild type strain. Therefore, the present invention was cultured until all the added glucose was consumed, from which the adapted progeny strains were obtained, and the strains were recovered through anaerobic culture, and the strains with improved succinic acid production capacity were selected. In addition, the genomes of the mutant strains were identified through genome sequencing of the parent strains and progeny strains, and the gene complementarity test was used to determine whether the mutations of the identified genes affected the increase in succinic acid production. In addition, a microbial evolution engineering method for producing a fermentation product succinic acid in high yield or high productivity by culturing the adapted progeny strain or artificially introduced strains identified in the progeny strain under anaerobic conditions was completed.
본 발명은 숙신산 생산능이 향상된, manXptsG 유전자가 결실된 대장균 K-12 균주에 추가적으로 exuR 유전자가 결실된 대장균 K-12 변이 균주를 제공한다.The present invention provides for further exuR gene is the E. coli K-12 mutant strain deleted for succinic acid production ability increased, the deletion manX E. coli ptsG gene and K-12 strains.
또한, 본 발명은 숙신산 생산능이 향상된, manXptsG 유전자가 결실된 대장균 K-12 균주에 추가적으로 agaR 유전자가 결실된 대장균 K-12 변이 균주를 제공한다.The present invention is further enhanced ability to produce succinic acid, and manX ptsG gene is deleted E. coli K-12 strain agaR Provided are E. coli K-12 variant strains that have been deleted.
또한, 본 발명은 숙신산 생산능이 향상된, manXptsG 유전자가 결실된 대장균 K-12 BW25113 균주에 추가적으로 exuRagaR 유전자가 결실된 대장균 K-12 변이 균주를 제공한다.The present invention is further exuR agaR and the succinic acid producing ability improved, manX ptsG gene and the E. coli K-12 strain BW25113 deletion Provided are E. coli K-12 variant strains that have been deleted.
또한, 본 발명은 숙신산 생산능이 향상된, manXptsG 유전자가 결실된 대장균 C 균주에 추가적으로 exuR 유전자가 결실된 대장균 C 변이 균주를 제공한다.The present invention also provides a succinic acid producing ability improved, manX ptsG gene and the gene deletion with the deletions are additionally exuR E. coli C strain E. coli C strain variation.
바람직하게는, 상기 대장균 C 변이 균주는 본 발명의 실시예에 기재된 Escherichia coli HK1014 균주로서, 수탁번호 KCTC13265BP로 기탁되었다.Preferably, the E. coli C variant strain is Escherichia coli HK1014 strain described in the embodiment of the present invention, deposited with accession number KCTC13265BP.
또한, 본 발명은 숙신산 생산능이 향상된, manXptsG 유전자가 결실된 대장균 C 균주에 추가적으로 agaR 유전자가 결실된 대장균 C 변이 균주를 제공한다.The present invention also provides a succinic acid producing ability improved, manX ptsG gene and the gene deletion with the deletions are additionally agaR E. coli C strain E. coli C strain variation.
또한, 본 발명은 숙신산 생산능이 향상된, manXptsG 유전자가 결실된 대장균 C 균주에 추가적으로 exuRagaR 유전자가 결실된 대장균 C 변이 균주를 제공한다.The present invention is further exuR agaR and the E. coli C strain with an improved, manX ptsG gene and acid production ability deletion Provided are E. coli C variant strains that have been deleted.
또한, 본 발명은 숙신산 생산능이 향상된, manXptsG 유전자가 결실된 대장균 C 균주에 exuRagaR 유전자가 결실된 대장균 C 변이 균주에 추가적으로 agaW, agaE, agaFagaA가 결실된 대장균 C 변이 균주를 제공한다.The invention also exuR agaR and the E. coli C strain is improved, and ptsG gene manX acid production ability deletion In addition to the E. coli C mutant strains, which are gene deleted, an E. coli C mutant strain lacking agaW , agaE , agaF and agaA is provided.
바람직하게는, 상기 대장균 C 변이 균주는 본 발명의 실시예에 기재된 Escherichia coli HK1017 균주로서, 수탁번호 KCTC13266BP로 기탁되었다.Preferably, the E. coli C variant strain is Escherichia coli HK1017 strain described in the embodiment of the present invention, deposited with accession number KCTC13266BP.
또한, 본 발명은 ptsI 유전자가 결실된 대장균 K-12 균주의 적응 진화(adaptive evolution) 배양 방법을 통해 얻은 균주로서, exuR 유전자가 추가적으로 결실된, 숙신산 생산능이 향상된 대장균 K-12 변이 균주를 제공한다.The present invention also ptsI gene is provided an adaptive evolution (adaptive evolution) as a strain obtained by the culture method, it enhanced E. coli K-12 mutant strain further the exuR gene ability deletions, succinic acid production in E. coli K-12 strain deleted .
상세하게는, 상기 적응 진화 배양 방법은 카나마이신이 포함된 배지에서 혐기 조건으로 배양할 수 있으나, 이에 한정되는 것은 아니다.Specifically, the adaptive evolution culture method may be cultured under anaerobic conditions in a medium containing kanamycin, but is not limited thereto.
바람직하게는, 상기 대장균 K-12 변이 균주는 본 발명의 실시예에 기재된 Escherichia coli HK950 균주로서, 수탁번호 KCTC13264BP로 기탁되었다.Preferably, the E. coli K-12 variant strain is Escherichia coli HK950 strain described in the embodiment of the present invention, deposited with accession number KCTC13264BP.
또한, 본 발명은 숙신산 생산능이 향상된, ptsI 유전자가 결실된 대장균 K-12 균주에 추가적으로 exuR 유전자가 결실된 대장균 K-12 변이 균주를 제공한다.In addition, the present invention provides an E. coli K-12 mutant strain, in which exuR gene is deleted, in addition to the E. coli K-12 strain, which is deleted from ptsI gene, which has improved succinic acid production capacity.
포도당 및 마노스당 특이적인 당수송계 유전자인 ptsGmanX를 결실시킨 대장균 K-12 BW25113 균주, 당수송계 복합체를 구성하는 유전자인 ptsI를 결실시킨 대장균 K-12 BW25113 균주 및 ptsG를 결실시킨 대장균 C 균주(KCTC2571)를 혐기적 조건에서 배양하였을 때 균주의 성장속도가 저하되는 특징을 갖는다. 이러한 균주성장 속도가 저하되는 조건에서 계속해서 혐기배양하여 첨가해준 포도당 50 mM을 전부 소모한 시점에서 배양액을 고체배지에 도말하여 자손균주를 얻는다. 이렇게 얻은 자손균주들을 다시 동일한 조건에서 혐기적으로 배양하였을 때는 균주의 성장속도가 회복되며, 숙신산의 생산능이 증가된 변이 균주를 선별할 수 있다. Glucose and town North specific leader transport system genes ptsG and manX was E. coli K-12 BW25113 strain, leader transport system complex in which Escherichia coli K-12 BW25113 strain and that E. coli C strain deleted for ptsG deleting a gene ptsI constituting the deletion per When (KCTC2571) is cultured under anaerobic conditions, the growth rate of the strain is reduced. Under the condition that the strain growth rate is lowered, the culture solution is plated on a solid medium at the time when 50 mM of all the glucose added by anaerobic culture is continuously consumed to obtain progeny strain. When the progeny strains thus obtained were again anaerobicly cultured under the same conditions, the growth rate of the strain was restored, and mutant strains with increased production capacity of succinic acid could be selected.
구체적으로 모균주인 대장균 K-12 BW25113 ΔptsG ΔmanX 균주는 50 mM 포도당으로부터 젖산은 생산되지 않고 숙신산은 31 mM을 생산하였으나 포도당을 모두 소모하는 데 84시간이 걸렸다. 이에 반해, 적응진화된 자손균주들의 경우는 36 시간 내에 포도당을 모두 소모하고 모균주에 비하여 빠르게 성장하였으며, 역시 부산물인 젖산은 생산되지 않고 개미산 및 에탄올의 생산은 매우 감소하는 것으로 나타났으며, 숙신산 생산량은 더욱 향상되어 36.7 ~ 40.3 mM 인 것으로 나타났다. 또한, 대장균 K-12 BW25113 ΔptsI 균주는 50 mM 포도당으로부터 젖산은 생산되지 않고 숙신산은 53 mM 생산하였으나 포도당을 모두 소모하는데 96 시간이 걸렸다. 이에 반해, 적응진화 된 자손균주들의 경우는 포도당을 모두 소모하는데 48 시간이 걸리며 모균주에 비하여 빠르게 성장하였으며, 부산물이 젖산은 생산되지 않고 개미산 및 에탄올의 생산은 매우 감소하는 것으로 나타났고, 숙신산 생산량은 매우 향상되어 51.9 ~ 54.4 mM 인 것으로 나타났다.Specifically, Escherichia coli K-12 BW25113 Δ ptsG Δ manX The strain produced no lactic acid from 50 mM glucose and succinic acid produced 31 mM, but it took 84 hours to consume all the glucose. On the contrary, the adapted progeny strains consumed all of the glucose within 36 hours and grew faster than the parent strains. Also, the production of formic acid and ethanol was significantly decreased, and lactic acid, a byproduct, was not produced. The yield was further improved and found to be 36.7-40.3 mM. In addition, E. coli K-12 BW25113 Δ ptsI The strain produced no lactate and 53 mM succinic acid from 50 mM glucose, but it took 96 hours to consume all the glucose. On the contrary, the adaptation of the progeny strains took 48 hours to consume all the glucose and grew faster than the parent strains. By-products showed no production of lactic acid and very low production of formic acid and ethanol. Was very improved and found to be 51.9-54.4 mM.
또한, 대장균 C (KCTC2571) ΔptsG 균주는 50 mM 포도당을 모두 소모하는데 66시간이 소요되었고 숙신산이 22.7 mM 생산되었으나, 적응진화된 자손균주의 경우는 50 mM 포도당을 모두 소모하는데 12시간이 소요되고, 숙신산은 18.6 ~ 20.3 mM 생산되는 것으로 나타났다. 따라서, 시간당 생성되는 숙신산의 생산량, 즉 생산성(productivity)이 향상되었다. In addition, the E. coli C (KCTC2571) Δ ptsG strain took 66 hours to consume all 50 mM glucose and produced 22.7 mM succinic acid, but the adapted progeny strain took 12 hours to consume all 50 mM glucose. Succinic acid has been shown to produce 18.6-20.3 mM. Thus, the yield of succinic acid produced per hour, ie productivity.
선별된 변이 자손균주의 유전체를 차세대 염기서열 해독 기술을 이용하여 분석하여 모균주의 유전체 서열과 비교·분석하여 돌연변이가 생성된 타겟 유전자를 확인하여 대장균 K-12 BW25113 ΔptsG ΔmanX가 적응진화되었을 경우 exuR 유전자에 돌연변이가 생성되었음을 확인하였고, 대장균 K-12 BW25113 ΔptsI가 적응진화 되었을 경우에도 exuR 유전자에 돌연변이가 생성되었음을 확인하였다. 또한, 대장균 C (KCTC2571) ΔptsG 균주에서 적응진화한 결과 agaR 유전자의 돌연변이를 확인할 수 있었다. 유전자 상보성 테스트(complementation test)로 exuRagaR 돌연변이가 대장균 K-12 BW25113 ΔptsG ΔmanX 대장균 C (KCTC2571) ΔptsG 균주의 성장속도를 빠르게 하며, 포도당으로부터 숙신산 생산량과 생산성을 각각 증가시킬 수 있음을 확인하였다. Genomes of the selected mutant progeny strains were analyzed using next-generation sequencing technology to compare and analyze the genome sequences of the parent strains to identify the target genes for which the mutations were generated.E. Coli K-12 BW25113 Δ ptsG If Δ is manX adaptive evolution was confirmed that a mutant gene is created on exuR, it was confirmed that the mutant gene is created on exuR even when the E. coli K-12 Δ BW25113 ptsI is adaptive evolution. In addition, E. coli C (KCTC2571) Δ ptsG Adaptive Evolution from Strains Mutations in the agaR gene were identified. Complementation tests show that exuR and agaR mutations can be found in E. coli K-12 BW25113 Δ ptsG With Δ manX E. coli C (KCTC2571) Δ ptsG It was confirmed that to increase the growth rate of the strain, and to increase the production and productivity of succinic acid from glucose, respectively.
특히, 대장균 C (KCTC2571) ΔptsG ΔagaR (aga- gam-) ΔexuR 균주의 경우, 50 mM 포도당을 모두 소모하는데 36시간이 소요되고, 숙신산은 42 mM이 생산되어 숙신산 생산수율이 증가되면서, 숙신산 생산성은 1.16 (mM/h)으로 크게 향상되었다. In particular, E. coli C (KCTC2571) Δ ptsG Δ agaR (aga- gam-) Δ exuR For the strain, it took 36 hours to consume all 50 mM glucose, succinic acid produced 42 mM to increase the yield of succinic acid, succinic acid productivity was significantly improved to 1.16 (mM / h).
또한 exuRagaR 유전자가 코딩하고 있는 ExuR 및 AgaR 전사조절인자의 돌연변이로 인하여 각각의 전사조절인자가 억제하는 유전자인 exuT , agaV , agaB 유전자의 mRNA의 양이 증가함을 qRT-PCR을 통하여 확인하였다. 따라서 ptsG , manX , ptsI 와 같은 당 수송계 유전자가 결실된 경우 ExuT 당수송단백질 또는 Aga 당수송단백질복합체를 통하여 세포내로 포도당이 수송될 수 있음을 확인하였다. Also exuR and agaR It was confirmed by qRT-PCR that the amount of mRNA of the genes exuT , agaV , agaB genes which are inhibited by the transcription regulators increased due to mutation of the ExuR and AgaR transcription regulators encoded by the gene. Thus it was when the transport system, such as a gene per ptsG, manX, ptsI deletion through a transport protein or Aga glucose transport protein complex per ExuT confirmed that the glucose into the cells can be transported.
또한, 본 발명은 상기 변이 균주를 배양하는 단계; 및 상기 배양액으로부터 숙신산을 수득하는 단계를 포함하는 숙신산의 생산방법을 제공한다.In addition, the present invention comprises the steps of culturing the variant strain; And it provides a method for producing succinic acid comprising the step of obtaining succinic acid from the culture.
상세하게는, 상기 배양하는 단계는 혐기 조건에서 수행될 수 있다.In detail, the culturing may be performed under anaerobic conditions.
결론적으로 당수송계 관련 유전자가 결실된 대장균 균주의 적응진화를 이용하여 숙신산 생산을 향상시킬 수 있는 유전자를 선별하고, 이를 인위적으로 대장균 균주에 도입한 결과, 숙신산 생산능이 크게 향상된 균주를 제조할 수 있었다. 이와 같이 본 발명은 진화공학을 이용한 숙신산 생산능이 향상된 변이 미생물 및 이를 이용한 숙신산 생산 방법을 제시한다. In conclusion, by using the adaptive evolution of E. coli strains lacking the sugar transport-related genes, a gene capable of improving succinic acid production was selected and introduced into the E. coli strain, resulting in a greatly improved succinic acid production capacity. . As described above, the present invention provides a mutant microorganism having improved succinic acid production ability using evolutionary engineering and a succinic acid production method using the same.
본 발명에 있어서, 상기 변이가 일어난 유전자의 NCBI Gene ID는 다음과 같다. manX (Gene ID: 946334), ptsG (Gene ID: 945651), exuR (Gene ID: 947602), agaR (Gene ID: 947636), agaW (Gene ID: 947647), agaE (Gene ID: 916505), agaF (Gene ID: 916152), agaA (Gene ID: 947646), 및 ptsI (Gene ID: 946879).In the present invention, the NCBI Gene ID of the gene having the mutation is as follows. manX (Gene ID: 946334), ptsG (Gene ID: 945651), exuR (Gene ID: 947602), agaR (Gene ID: 947636), agaW (Gene ID: 947647), agaE (Gene ID: 916505), agaF (Gene ID: 916152), agaA (Gene ID: 947646), and ptsI (Gene ID: 946879).
본 발명에서 적응진화를 이용하여 새롭게 규명한 ExuT 당수송단백질과 Aga 당수송 단백질 복합체는 새로운 대사공학의 타겟이 될 수 있다. 특히 숙신산 생산 균주로 개발되어 있는 기존의 여러가지 대장균 균주에 도입하여 숙신산 생산 증대에 활용이 가능하다. 또한 숙신산 생산 반추미생물 등에 본 발명의 포도당 수송계를 도입하여 숙신산 생산 증대에 활용할 수 있다.In the present invention, the newly identified “ExuT” sugar transport protein and “Aga” sugar transport protein complex using adaptive evolution may be the target of new metabolic engineering. In particular, it can be used to increase the production of succinic acid by introducing into various existing E. coli strains that have been developed as succinic acid producing strains. In addition, the glucose transport system of the present invention may be used to increase succinic acid production in succinic acid-producing ruminants.
본 발명에서 ‘결실’이란 해당 유전자의 일부 또는 전체 염기를 변이, 치환, 또는 삭제시키거나, 일부 염기를 도입시켜 해당유전자가 발현되지 않도록 하거나 발현되더라도 효소활성을 나타내지 못하도록 하는 것을 포괄하는 개념으로, 해당 유전자의 효소가 관여하는 생합성 경로를 차단하는 모든 것을 포함한다. In the present invention, the term 'deletion' is a concept encompassing a part or whole base of the gene, mutating, substituting or deleting, or introducing some base so that the gene is not expressed or does not exhibit enzymatic activity even when expressed. It includes everything that blocks the biosynthetic pathways involved in the enzymes of the gene.
또한, 본 발명에서 모균주는 미생물의 성장속도가 저하되어 있거나 목적하는 발효산물을 잘 생산하지 못하는 균주로 야생형 혹은 특정 유전자 돌연변이주 모두 가능하다. 또한, 자손균주는 모균주의 유전체에 갖고 있지 않는 돌연변이를 가짐으로 인해서, 모균주에 비하여 균주의 성장속도가 빠르게 회복되었고, 목적하는 발효산물을 고수율(high yield) 또는 고생산성(high productivity)으로 생산하는 균주이다. 또한, 적응진화는 성장속도가 저하되어 있는 모균주를 포도당과 같은 탄소원이 고갈될 때까지 배양한 후에 고체배지에 도말하여 성장속도가 빨라진 자손균주를 선별해서 얻는 과정이다. In addition, the parent strain in the present invention is a strain in which the growth rate of the microorganism is reduced or does not produce the desired fermentation product well, both wild-type or specific gene mutants. In addition, the progeny strain had a mutation not possessed in the genome of the parent strain, so that the growth rate of the strain was recovered faster than that of the parent strain, and the desired fermentation product had a high yield or high productivity. It is a strain produced by. In addition, the adaptive evolution is a process of obtaining the offspring strains which have been grown at a rapid growth rate by culturing the parent strains with low growth rate until the carbon source such as glucose is depleted, and then spreading them on a solid medium.
본 발명에 있어서, 상기 적응진화에 사용되는 배지는 특별히 제한되지 않으나, 초기 탄소원으로 포도당 농도가 바람직하게는 8~20 g/L이고, 가장 바람직하게는 9 g/L이며, 배양은 35~45℃, 바람직하게는 35~39℃, 가장 바람직하게는 37℃의 온도와, 6.0~7.5, 바람직하게는 6.3~6.7, 가장 바람직하게는 6.5의 초기 pH 조건하에서 수행될 수 있다. 또한, 상기 배양은 혐기적 조건에서 수행하는 것이 바람직한데, 혐기적 조건은 질소를 배양기의 head space에 공급하고, Na2S를 첨가하여 액체배지내의 용존산소를 제거함으로써 형성할 수 있다. 상기 배양기는 특별한 제한은 없으나 serum bottle를 예시할 수 있다. In the present invention, the medium used for the adaptive evolution is not particularly limited, but the glucose concentration is preferably 8-20 g / L, most preferably 9 g / L as the initial carbon source, and the culture is 35-45. It can be carried out under a temperature of ℃, preferably 35 ~ 39 ℃, most preferably 37 ℃, and initial pH conditions of 6.0 ~ 7.5, preferably 6.3 ~ 6.7, most preferably 6.5. In addition, the culture is preferably carried out under anaerobic conditions, anaerobic conditions can be formed by supplying nitrogen to the head space of the incubator, by adding Na 2 S to remove dissolved oxygen in the liquid medium. The incubator is not particularly limited but may exemplify a serum bottle.
이하, 본 발명의 이해를 돕기 위하여 실시예를 들어 상세하게 설명하기로 한다. 다만 하기의 실시예는 본 발명의 내용을 예시하는 것일 뿐 본 발명의 범위가 하기 실시예에 한정되는 것은 아니다. 본 발명의 실시예는 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해 제공되는 것이다.Hereinafter, examples will be described in detail to help understand the present invention. However, the following examples are merely to illustrate the content of the present invention is not limited to the scope of the present invention. The embodiments of the present invention are provided to more completely explain the present invention to those skilled in the art.
<< 실시예Example 1>  1> 당수송계Party transport system 유전자 결실  Gene deletion 모균주의Fungus 제작과  Production department 혐기배양Anaerobic Culture
미생물 균주의 유전체에 각 단일 및 복수 돌연변이 유전자 도입은 P1 transduction 방법을 통한 상동성 재조합을 이용하여 제작하였다. P1 transduction을 위한 P1 lysate 제작은 다음과 같이 수행하였다. 먼저 당수송계에 관련된 ptsG ptsI 유전자가 카나마이신(kanamycin) 내성 유전자로 치환되어 있는 돌연변이 대장균 균주(E. coli ΔptsG::KmR, E. coli ΔptsI::KmR)는 KEIO collection을 통하여 입수하였으며, 각 균주를 카나마이신이 25 ㎍/㎖로 포함된 LB 고체배지에 도말하고, 자라난 단일 콜로니를 0.01 M MgSO4, 0.005 M CaCl2를 포함한 LB 액체배지 25 ㎖에 접종하여 37℃에서 OD600nm가 0.4가 될 때까지 배양하고, P1 박테리오파지를 250 ㎕를 접종하여 각 돌연변이 균주를 용해시키기 위하여, 37℃에서 4시간 더 배양하였다. 균주가 용해된 25 ㎖ 배양액에 500 ㎕의 클로로포름을 섞은 후, 3000 rpm에서 10분 동안 원심분리하여 용해된 세포 침전물을 제외한 상등액을 취하고, 이는 돌연변이 균주가 용해되면서 단일 결실 유전자형(ΔptsG::KmR, ΔptsI::KmR)을 보유하고 있는 P1 박테리오파지를 포함하는 각각의 P1 Lysate로 제조하였다. Each single and multiple mutant genes were introduced into the genome of the microbial strain using homologous recombination through the P1 transduction method. Preparation of P1 lysate for P1 transduction was performed as follows. First, ptsG related to sugar transport system And mutant E. coli strain in ptsI gene is replaced with the kanamycin (kanamycin) resistance gene (E. coli Δ ptsG :: KmR, E. coli Δ ptsI :: KmR) was obtained through the KEIO collection, kanamycin is 25 ㎍ each strain Smear LB solid medium containing / ml, incubated single colonies in 25 ml LB liquid medium containing 0.01 M MgSO 4 , 0.005 M CaCl 2 and incubated at 37 ℃ until OD 600nm becomes 0.4, To inoculate 250 μl of P1 bacteriophage to dissolve each mutant strain, the cells were further incubated at 37 ° C. for 4 hours. 500 μl of chloroform was mixed in a 25 ml culture in which the strain was dissolved, followed by centrifugation at 3000 rpm for 10 minutes to obtain the supernatant except the lysed cell precipitate, which was mutated and the single deletion genotype (Δ ptsG :: KmR was dissolved. , P1 Lysate containing P1 bacteriophage with Δ ptsI :: KmR).
제조된 P1 lysate를 감염시켜 유전자 결실을 도입시킬 K-12 BW25113 (CGSC7636, The Coli Genetic Stock Center, Yale University) 야생형 수용균주는 0.01 M MgSO4, 0.005 M CaCl2를 포함한 LB 액체배지에 접종하여 배양한 후 5000 rpm에서 원심분리하여 배지는 제거하고, 세포침전물(cell pellets)을 0.01 M MgSO4, 0.005 M CaCl2를 포함한 LB 액체배지 1 ㎖로 현탁시켰다. 앞서 준비된 P1 Lysate와 유전자 결실을 도입시킬 야생형 수용균주를 100 ㎕씩 각각 섞은 후, 37℃에서 20분 배양하고 1 M Na+·Citrate·2H2O을 100 ㎕를 가하여 잘 섞어 25 ㎍/㎖ 의 카나마이신이 포함된 LB 고체배지에 도말하여 37℃에서 배양함으로써, 카나마이신 내성으로 치환된 유전자의 결실(ΔptsG::KmR, ΔptsI::KmR)이 도입된 각각의 대장균 균주인 HK620 및 HK898을제조하였다.K-12 BW25113 (CGSC7636, The Coli Genetic Stock Center, Yale University) wild type strains to infect the prepared P1 lysate to induce gene deletion were cultured by inoculating LB liquid medium containing 0.01 M MgSO 4 , 0.005 M CaCl 2 . centrifuged at 5000 rpm after which the medium was removed, and the precipitate was suspended in the cell (cell pellets) of 0.01 M MgSO 4, 0.005 1 ㎖ LB broth containing the M CaCl 2. After mixing 100 μl each of the P1 lysate prepared above and the wild type strain to introduce the gene deletion, incubate at 37 ° C. for 20 minutes, add 100 μl of 1 M Na + · Citrate · 2H 2 O and mix well to obtain 25 μg / ml. Staining LB solid medium containing kanamycin and incubating at 37 ° C. to prepare the respective E. coli strains HK620 and HK898 in which the deletion of the gene substituted with kanamycin resistance (Δ ptsG :: KmR, Δ ptsI :: KmR) was introduced. It was.
포도당 및 마노스당 특이적인 당수송계 유전자인 ptsG manX 둘 다 모두 결실시킨 대장균 K-12 BW25113 균주는 다음과 같이 제작하였다. 먼저, manX 유전자 각각이 카나마이신 내성 유전자로 치환되어 있는 단일 결실 돌연변이 균주는 KEIO collection에서 입수하였다. 상기의 P1 transduction을 수행하여 제작한 HK620 균주에 pCP20 (CGSC7629, The Coli Genetic Stock Center, Yale University)를 형질전환시켜 앰피실린(ampicillin)이 50㎍/㎖ 포함된 LB 고체배지에 도말하여 유전체에서 FRT서열의 상동성재조합을 유도하여 카나마이신 내성 유전자만을 결실시킨 HK812 균주(대장균 K-12 BW25113 ΔptsG)를 제작하였다. 다시 말해, HK812균주는 ptsG 유전자 결실을 갖고 있지만 카나마이신 내성은 가지지 않는다. 이러한 HK812균주를 수용균주로 하고, manX 결실 돌연변이를 균주(ΔmanX::KmR)를 공여균주로 하여 제작한 P1 lysate를 감염시켜 P1 transduction을 수행하여 대장균 K-12 BW25113 ΔptsGΔmanX::KmR 균주를 제작하고, 이를 모균주 HK907로 명명하였다. Glucose and manos sugar-specific sugar transport genes ptsG And manX Both E. coli K-12 BW25113 strains were prepared as follows. first, A single deletion mutant strain in which each manX gene was substituted with a kanamycin resistance gene was obtained from the KEIO collection. PK20 (CGSC7629, The Coli Genetic Stock Center, Yale University) was transformed into the HK620 strain prepared by the above P1 transduction, and plated on 50 μg / mL of ampicillin (ampicillin) in an LB solid medium. Homologous recombination of the sequences was induced to construct an HK812 strain (E. coli K-12 BW25113 Δ ptsG ), in which only the kanamycin resistance gene was deleted. In other words, strain HK812 has a ptsG gene deletion but kanamycin resistance does not possess. These HK812 strain to accommodate strain and, manX deletion mutant strain (Δ manX :: KmR) to infect a P1 lysate prepared by a donor strain by P1 transduction of the E. coli K-12 performed BW25113 Δ Δ ptsG manX :: KmR A strain was produced and named parent strain HK907.
포도당 특이적인 ptsG를 결실시킨 대장균 C (KCTC2571, Korean Collection for Type Cultures) 균주는 다음과 같이 제작하였다. 야생형 수용균주인 대장균 C 균주에 ptsG 단일 결실돌연변이를 공여균주로 하여 P1 transduction을 수행하여 HK864 균주를 제작하였고 이를 모균주로 하였다. 그런데, 대장균 C 균주의 경우 마노스당 특이적인 당수송계 유전자인 manX 유전자에 IS 삽입으로 인하여 이미 불활성화 되어 있다. Escherichia coli C (KCTC2571, Korean Collection for Type Cultures) strain which deleted glucose specific ptsG was prepared as follows. To the ptsG single deletion mutation in the E. coli C strain wild-type strain to accommodate the donor strain HK864 strain was produced by performing the P1 transduction As a result, a parent strain. By the way, in the case of E. coli strain C, manX , a sugar-specific gene for sugar transport, It is already inactivated due to IS insertion into the gene.
제작된 모균주 HK907, HK898 및 HK864는 각각 카나마이신이 25μg/㎖ 농도로 포함된 LB 고체배지에 도말하고, 성장한 단일 콜로니를 LB 액체배지 5 ㎖에 접종하여 37℃에서 12시간 전배양 하였다. 상기 배양액을 발효배지 (glucose, 9g (final 50 mM); yeast extract, 5g; NaHCO3, 10g; NaH2PO4·H2O, 8.5g; K2HPO4, 15.5g per liter (pH7.0)) 100 ㎖이 들어있는 125 ㎖ 크기의 serum bottle에 1ml 접종하고, Na2S가 1 mM 되도록 첨가하여 밀봉한 후, 상층부를 질소가스로 충전하여 serum bottle 내의 산소를 제거하고 37℃에서 배양하고 6시간마다 균주의 성장과 발효산물을 분석하였다. 균주의 성장과 발효산물 분석은 각 균주의 배양액을 1 ml 취하여, 100 ul를 PBS에 1:10으로 희석하고 OD600nm 값을 측정하여 균주의 성장을 분석하였고, 남아 있는 배양액은 12000 rpm에서 10분간 원심분리하고 0.2 um 나일론 필터를 사용하여 배양액을 여과하고 이 여과액을 HPLC 분석에 이용하였다. 포도당, 숙신산, 젖산, 개미산, 아세트산 및 에탄올의 분석은 Aminex HPX-87H column (Bio-rad)을 사용하였으며, 이동상으로는 0.1 N H2SO4 용액을 사용하였다. The prepared parent strains HK907, HK898, and HK864 were plated on LB solid medium containing kanamycin at 25 μg / mL, respectively, and inoculated with 5 mL of LB liquid medium, and grown at 37 ° C. for 12 hours. Medium to the fermentation culture medium (glucose, 9g (final 50 mM ); yeast extract, 5g; NaHCO 3, 10g; NaH 2 PO 4 · H 2 O, 8.5g; K 2 HPO 4, 15.5g per liter (pH7.0 1) Inoculate 1 ml into a 125 ml serum bottle containing 100 ml, add 1 ml of Na 2 S, seal it, and fill the upper layer with nitrogen gas to remove oxygen from the serum bottle and incubate at 37 ° C. Strain growth and fermentation products were analyzed every 6 hours. For growth and fermentation analysis of strains, 1 ml of each strain was taken, 100 ul was diluted 1:10 in PBS, and the OD 600nm value was measured to analyze the growth of the strain. The remaining culture was 10 minutes at 12000 rpm. Centrifuge and filter the culture using a 0.2 um nylon filter and use this filtrate for HPLC analysis. Glucose, succinic acid, lactic acid, formic acid, acetic acid and ethanol were analyzed using an Aminex HPX-87H column (Bio-rad) and 0.1 NH 2 SO 4 solution as the mobile phase.
모균주의 HK907, HK898 및 HK864의 혐기조건에서 성장 및 발효산물의 생산량을 도 1에 나타내었다. 도 1에 나타난 바와 같이, HK907 균주는 약 48 시간의 지연기를 가진 후에 균주의 성장이 관찰되었으며, 50 mM 포도당을 모두 소모하는데 84시간이 소요되며, 이때 숙신산 생산량은 31.7 mM 이었으며, HK898 균주는 약 54시간의 지연기를 가진 후에 균주의 성장이 관찰되었으며, 50 mM 포도당을 모두 소모하는데 96시간이 소요되며, 이때 숙신산 생산량은 53.5 mM 로 확인되었다. 또한, HK864 균주는 약 36 시간의 지연기를 가진 후에 균주의 성장이 관찰되었으며, 50 mM 포도당을 모두 소모하는데 66 시간이 소요되었고, 이때 숙신산 생산량은 22.7 mM 으로 나타났다(도 1). Figure 1 shows the growth and fermentation yield of the parent strain under anaerobic conditions of HK907, HK898 and HK864. As shown in FIG. 1, the growth of the strain was observed after the HK907 strain had a delay period of about 48 hours, and it took 84 hours to consume all 50 mM glucose, wherein the succinic acid production was 31.7 mM, and the HK898 strain was about After 54 hours of delay, the growth of the strain was observed and it took 96 hours to consume all 50 mM glucose, with succinic acid production of 53.5 mM. In addition, the growth of the strain was observed after the HK864 strain had a delay period of about 36 hours, it took 66 hours to consume all 50 mM glucose, the succinic acid production was 22.7 mM (Fig. 1).
<< 실시예Example 2> 적응진화된  2> adapted 자손균주의Progeny 숙신산 생산량과 생산성 향상 Succinic Acid Production and Productivity Improvement
실시예 1의 포도당을 모두 소모한 모균주의 배양액을 LB 고체배지에 도말하여 자손균주의 단일콜로니들을 얻는다. 각각의 자손균주 단일콜로니들을 모균주와 같은 방법으로 전배양하고, 발효배지에서 혐기적으로 배양하였다. 배양결과, 자손균주들 중에서 지연기가 없고 성장속도가 빨라진 균주들을 선별하여 첨가해준 포도당이 모두 소모되었는지 확인하였다 (도 2). Single culture colonies of progeny strains are obtained by spreading the culture medium of the parent strains that have consumed all of the glucose of Example 1 onto LB solid medium. Single progeny colonies of each progeny strain were precultured in the same manner as the parent strain, and were anaerobicly cultured in fermentation broth. As a result of the culture, it was confirmed that all of the added glucose was consumed by selecting strains having no delay and growth rate among progeny strains (FIG. 2).
HK907의 자손균주는 6종 (HK953, HK954, HK955, HK956, HK957, HK958)이 선별되었고, 혐기배양 36시간 내에 포도당을 모두 소모하였으며, 숙신산 생산량은 약 36.7 ~ 40.3 mM 인 것으로 나타났다 (표 1). 따라서, 모균주 HK907에 비해 자손균주들의 배양시간은 48시간 단축되었으며, 숙신산의 생산량은 5 ~ 8.6 mM가 증가하였고, 숙신산 생산성도 증가하였다.HK907 progeny strains (HK953, HK954, HK955, HK956, HK957, HK958) were selected and consumed all of the glucose within 36 hours of anaerobic culture. . Therefore, compared to the parent strain HK907, the incubation time of the progeny strains was reduced by 48 hours, the production of succinic acid was increased by 5 ~ 8.6 mM, and the productivity of succinic acid was also increased.
대장균K-12균주Escherichia coli K-12 strain 유전자형genotype OD600 OD 600 발효산물의 농도 (mM)Fermentation Concentration (mM) 시간 (h)†Time (h) † 숙신산 생산성(mM/h)Succinic Acid Productivity (mM / h)
포도당glucose 아세트산Acetic acid 에탄올ethanol 개미산Formic acid 젖산Lactic acid 숙신산Succinic acid
BW25113BW25113 Wild-typeWild-type 5.6 5.6 ND§ND§ 34.234.2 34.034.0 61.761.7 9.69.6 5.15.1 6 6 0.850.85
HK620HK620 ΔptsG::KmRΔ ptsG :: KmR 2.7 2.7 NDND 40.840.8 29.129.1 58.358.3 5.25.2 21.821.8 48 48 0.450.45
HK907(모균주)HK907 (parent strain) ΔptsG ΔmanX::KmRΔ ptsG Δ manX :: KmR 3.0 3.0 NDND 44.7 44.7 18.5 18.5 58.5 58.5 ND ND 31.7 31.7 84 84 0.380.38
HK953(자손균주)HK953 (offspring strain) ΔptsG ΔmanX::KmRΔ ptsG Δ manX :: KmR 4.3 4.3 NDND 38.7 38.7 11.5 11.5 39.9 39.9 ND ND 36.7 36.7 36 36 1.021.02
HK954(자손균주)HK954 (offspring strain) ΔptsG ΔmanX::KmRΔ ptsG Δ manX :: KmR 4.3 4.3 NDND 38.6 38.6 11.6 11.6 39.5 39.5 ND ND 36.9 36.9 36 36 1.031.03
HK955(자손균주)HK955 (offspring strain) ΔptsG ΔmanX::KmRΔ ptsG Δ manX :: KmR 4.5 4.5 NDND 34.4 34.4 15.8 15.8 28.8 28.8 ND ND 38.3 38.3 36 36 1.061.06
HK956(자손균주)HK956 (offspring strain) ΔptsG ΔmanX::KmRΔ ptsG Δ manX :: KmR 4.3 4.3 NDND 33.9 33.9 16.9 16.9 25.7 25.7 ND ND 40.2 40.2 36 36 1.121.12
HK957(자손균주)HK957 (offspring strain) ΔptsG ΔmanX::KmRΔ ptsG Δ manX :: KmR 4.3 4.3 NDND 33.7 33.7 17.1 17.1 25.1 25.1 ND ND 40.3 40.3 36 36 1.121.12
HK958(자손균주)HK958 (offspring strain) ΔptsG ΔmanX::KmRΔ ptsG Δ manX :: KmR 4.2 4.2 NDND 34.1 34.1 16.8 16.8 26.5 26.5 ND ND 39.8 39.8 36 36 1.111.11
†첨가해준 50 mM을 모두 소모하는데 소요되는 시간을 나타냄.§ND, Not detected.† Indicates time spent consuming all 50 mM added. § ND, Not detected.
그리고, HK898의 자손균주는 6종 (HK947, HK948, HK949, HK950, HK951, HK952)이 선별되었고, 혐기배양 48시간 내에 포도당을 모두 소모하였으며, 숙신산 생산량은 약 51.9 ~ 54.4 mM 인 것으로 나타났다 (표 2). 따라서, 모균주 HK898에 비해 자손균주들의 배양시간은 48시간 단축되었으며, 숙신산의 생산량은 거의 차이가 없지만, 숙신산 생산성은 증가하였다.In addition, six HK898 progeny strains (HK947, HK948, HK949, HK950, HK951, HK952) were selected, consumed all the glucose within 48 hours of anaerobic culture, and succinic acid production was found to be 51.9-54.4 mM (Table 1). 2). Therefore, compared to the parent strain HK898, the incubation time of the progeny strains was shortened by 48 hours, the production of succinic acid is almost no difference, but succinic acid productivity was increased.
대장균K-12균주Escherichia coli K-12 strain 유전자형genotype OD600 OD 600 발효산물의 농도 (mM)Fermentation Concentration (mM) 시간 (h)†Time (h) † 숙신산 생산성(mM/h)Succinic Acid Productivity (mM / h)
포도당glucose 아세트산Acetic acid 에탄올ethanol 개미산Formic acid 젖산Lactic acid 숙신산Succinic acid
BW25113BW25113 Wild-typeWild-type 5.65.6 ND§ND§ 34.234.2 34.034.0 61.761.7 9.69.6 5.15.1 6 6 0.850.85
HK898(모균주)HK898 (parent strain) ΔptsI::KmRΔ ptsI :: KmR 2.22.2 NDND 27.527.5 1.81.8 30.530.5 NDND 53.453.4 9696 0.560.56
HK947(자손균주)HK947 (offspring strain) ΔptsI::KmRΔ ptsI :: KmR 3.13.1 NDND 29.129.1 5.85.8 5.15.1 ND ND 52.852.8 4848 1.101.10
HK948(자손균주)HK948 (offspring strain) ΔptsI::KmRΔ ptsI :: KmR 3.03.0 NDND 29.629.6 5.05.0 6.46.4 ND ND 52.652.6 4848 1.101.10
HK949(자손균주)HK949 (offspring strain) ΔptsI::KmRΔ ptsI :: KmR 2.92.9 NDND 29.329.3 5.15.1 6.16.1 ND ND 52.852.8 4848 1.101.10
HK950(자손균주)HK950 (offspring strain) ΔptsI::KmRΔ ptsI :: KmR 2.92.9 NDND 29.729.7 5.15.1 7.77.7 ND ND 51.951.9 4848 1.081.08
HK951(자손균주)HK951 (offspring strain) ΔptsI::KmRΔ ptsI :: KmR 2.92.9 NDND 29.629.6 5.95.9 3.83.8 ND ND 54.454.4 4848 1.131.13
HK952(자손균주)HK952 (offspring strain) ΔptsI::KmRΔ ptsI :: KmR 2.92.9 NDND 30.830.8 5.15.1 9.59.5 ND ND 51.951.9 4848 1.081.08
†첨가해준 50 mM을 모두 소모하는데 소요되는 시간을 나타냄.§ND, Not detected.† Indicates time spent consuming all 50 mM added. § ND, Not detected.
또한, HK864의 자손균주는 4종 (HK878, HK879, HK880, HK881)이 선별되었으며, 이 자손균주들은 12시간에 포도당을 모두 소모하였으며, 이 때 숙신산 생산량은 18.6 ~ 20.3 mM 인 것으로 나타났다 (표 3). 따라서, 모균주 HK864에 비해 자손균주들의 배양시간은 54시간 단축되었으므로, 시간당 숙신산 생성량, 즉 생산성(productivity)이 4.6 ~ 5배 가량 증가하였다.In addition, four progeny strains of HK864 (HK878, HK879, HK880, HK881) were selected, and these progeny strains consumed all the glucose at 12 hours, and the production of succinic acid was 18.6 ~ 20.3 mM (Table 3). ). Therefore, compared to the parent strain HK864, the growth time of the progeny strains was shortened by 54 hours. Thus, the production of succinic acid per hour, that is, the productivity (productivity) increased by about 4.6-5 times.
대장균C 균주E. coli strain 유전자형genotype OD600 OD 600 발효산물의 농도 (mM)Fermentation Concentration (mM) 시간 (h)Time (h) 숙신산 생산성(mM/h)Succinic Acid Productivity (mM / h)
포도당glucose 아세트산Acetic acid 에탄올ethanol 개미산Formic acid 젖산Lactic acid 숙신산Succinic acid
KCTC2571KCTC2571 manX::IS manX :: IS 5.4 5.4 ND§ND§ 32.432.4 29.229.2 54.254.2 17.417.4 6.26.2 6 6 1.031.03
HK864(모균주)HK864 (parent strain) manX::ISΔptsG::KmR manX :: ISΔ ptsG :: KmR 3.5 3.5 NDND 38.938.9 29.829.8 50.850.8 4.24.2 22.722.7 66 66 0.340.34
HK878(자손균주)HK878 (offspring strain) manX::ISΔptsG::KmR manX :: ISΔ ptsG :: KmR 5.5 5.5 NDND 40.0 40.0 27.0 27.0 60.7 60.7 1.5 1.5 20.3 20.3 12 12 1.691.69
HK879(자손균주)HK879 (offspring strain) manX::ISΔptsG::KmR manX :: ISΔ ptsG :: KmR 5.5 5.5 NDND 35.3 35.3 33.2 33.2 38.1 38.1 1.6 1.6 20.2 20.2 12 12 1.681.68
HK880(자손균주)HK880 (offspring strain) manX::ISΔptsG::KmR manX :: ISΔ ptsG :: KmR 5.6 5.6 NDND 36.9 36.9 31.9 31.9 53.4 53.4 1.3 1.3 20.0 20.0 12 12 1.671.67
HK881(자손균주)HK881 (offspring strain) manX::ISΔptsG::KmR manX :: ISΔ ptsG :: KmR 5.2 5.2 NDND 40.2 40.2 31.5 31.5 62.7 62.7 2.3 2.3 18.6 18.6 12 12 1.551.55
첨가해준 50 mM을 모두 소모하는데 소요되는 시간을 나타냄.§ND, Not detected. Indicates time spent consuming all 50 mM added. § ND, Not detected.
<실시예 3> 유전체 분석을 통한 자손균주의 돌연변이 유전자 확인Example 3 Identification of Mutant Genes of Progeny Strains by Genomic Analysis
균주의 성장이 회복되고 숙신산 생산량이 증가한 자손균주의 유전체 분석을 통하여 돌연변이 타겟 유전자를 확인하였다. 유전체 분석에 사용할 모균주 (HK907, HK878, HK864) 및 자손균주 (HK956, HK949, HK878, HK881)의 단일콜로니를 5ml LB 액체배지에 접종하고, 37℃에서 16시간 배양하고 배양액 1ml을 3000 rpm, 10분간 원심분리하여 상등액을 제거하고 균체를 회수하였다. 균체는 Wizard Genomic DNA purification kit (Promega)를 사용하여 균주 유전체 DNA를 분리하였다. 유전체 분석은 대용량 유전체 해독 장비인 HiSeq2000을 활용하였으며, 라이브러리 제작은 Illumina의 표준방법 (Sample DNA의 A260/280 ratio가 1.8 이상, 최소농도 100 ng/㎕ 이상, total amount 5 ㎍ 이상)을 준수하였고, 서열 데이터의 전처리 및 서열 단편 조립을 실시하여 모균주의 유전체 염기서열과 자손균주의 유전체 염기서열을 비교·분석하여 자손균주에서 새롭게 획득한 돌연변이를 확인하였다. Mutant target genes were identified through genome analysis of progeny strains with increased growth and increased succinic acid production. Single colonies of parent strains (HK907, HK878, HK864) and progeny strains (HK956, HK949, HK878, HK881) to be used for genome analysis were inoculated in 5 ml LB liquid medium, incubated at 37 ° C for 16 hours, and 1 ml of the culture was 3000 rpm, The supernatant was removed by centrifugation for 10 minutes and the cells were recovered. Cells were isolated from strain genomic DNA using Wizard Genomic DNA purification kit (Promega). For genome analysis, HiSeq2000, a large-capacity genome detoxification instrument, was used, and the library production was in compliance with Illumina's standard method (A260 / 280 ratio of Sample DNA over 1.8, minimum concentration over 100 ng / μl, total amount over 5 μg), Pretreatment of the sequence data and assembly of sequence fragments were performed to compare and analyze the genome sequences of the parent strain and the genome sequences of the progeny strain to identify newly acquired mutations in the progeny strain.
유전체 염기서열 분석결과 HK907의 자손균주인 HK956에서는 전사조절인자인 ExuR 단백질을 코딩하고 있는 exuR 유전자의 431번 염기 다음에 5개의 염기가 결실되어 있는 것을 확인하였다. 이를 바탕으로 다른 자손 균주인 HK953, HK954, HK955, HK957, 및 HK958에서 exuR 유전자 부위를 PCR로 증폭하여 sanger sequencing 방법으로 염기서열을 분석하였을 때, exuR 유전자에 다른 유형의 돌연변이가 있음을 확인하였다 (표 4). Genomic sequencing revealed that exuR, which encodes the transcriptional regulator ExuR protein, in HK956, the offspring of HK907. It was confirmed that 5 bases were deleted after the 431 base of the gene. Based on this, exuR in other progeny strains HK953, HK954, HK955, HK957, and HK958 ExuR when the sequence was analyzed by sanger sequencing method by amplifying the gene region by PCR It was confirmed that there are other types of mutations in the genes (Table 4).
균주Strain 유전자형genotype 적응진화 돌연변이Adaptive evolution mutations
대장균K-12 균주Escherichia coli K-12 strain BW25113BW25113 Wild-typeWild-type --
HK620HK620 ΔptsG::KmRΔ ptsG :: KmR --
HK907 (모균주)HK907 (parent strain) ΔptsG ΔmanX::KmRΔ ptsG Δ manX :: KmR --
HK953 (자손균주)HK953 (offspring strain) ΔptsG ΔmanX::KmRΔ ptsG Δ manX :: KmR exuR G500A (W167Z) exuR G500A (W167Z)
HK954 (자손균주)HK954 (offspring strain) ΔptsG ΔmanX::KmRΔ ptsG Δ manX :: KmR exuR T467A (L159Q) exuR T467A (L159Q)
HK955 (자손균주)HK955 (offspring strain) ΔptsG ΔmanX::KmRΔ ptsG Δ manX :: KmR exuR::IS30 exuR :: IS30
HK956* (자손균주)HK956 * (offspring strain) ΔptsG ΔmanX::KmRΔ ptsG Δ manX :: KmR exuR 5 bp deletion after T431 exuR 5 bp deletion after T431
HK957 (자손균주)HK957 (offspring strain) ΔptsG ΔmanX::KmRΔ ptsG Δ manX :: KmR exuR::IS60 (1226 bp) after C360 exuR :: IS60 (1226 bp) after C360
HK958 (자손균주)HK958 (offspring strain) ΔptsG ΔmanX::KmRΔ ptsG Δ manX :: KmR exuR T167A (L56Q) exuR T167A (L56Q)
*유전체 분석을 수행한 균주임.* Strains were subjected to genome analysis.
그리고, HK898의 자손균주인 HK949 에서는 전사조절인자인 ExuR 단백질을 코딩하고 있는 exuR 유전자의 531번 염기 다음에 127개의 염기가 결실되어 있는 것을 확인하였다. 이를 바탕으로 다른 자손 균주인 HK947, HK948, HK950, HK951, 및 HK952에서 exuR 유전자 부위를 PCR로 증폭하여 sanger sequencing 방법으로 염기서열을 분석하였을 때, exuR 유전자에 다른 유형의 돌연변이가 있음을 확인하였다 (표 5). Then, in the progeny of the HK898 strain HK949 exuR that encoding a transcription factor protein ExuR It was confirmed that 127 bases were deleted after base 531 of the gene. Based on this, exuR in other progeny strains HK947, HK948, HK950, HK951, and HK952 ExuR when the sequence was analyzed by sanger sequencing method by amplifying the gene region by PCR It was confirmed that there are other types of mutations in the genes (Table 5).
균주Strain 유전자형genotype 적응진화 돌연변이Adaptive evolution mutations
대장균K-12 균주Escherichia coli K-12 strain BW25113BW25113 Wild-typeWild-type --
HK898(모균주)HK898 (parent strain) ΔptsI::KmRΔ ptsI :: KmR --
HK947(자손균주)HK947 (offspring strain) ΔptsI::KmRΔ ptsI :: KmR exuR C304T (Q102Z) exuR C304T (Q102Z )
HK948(자손균주)HK948 (offspring strain) ΔptsI::KmRΔ ptsI :: KmR exuR C304T (Q102Z) exuR C304T (Q102Z)
HK949*(자손균주)HK949 * (offspring strain) ΔptsI::KmRΔ ptsI :: KmR exuR 127 bp deletion after A531 exuR 127 bp deletion after A531
HK950(자손균주)HK950 (offspring strain) ΔptsI::KmRΔ ptsI :: KmR exuR::IS1 (777 bp) after A171 exuR :: IS1 (777 bp) after A171
HK951(자손균주)HK951 (offspring strain) ΔptsI::KmRΔ ptsI :: KmR exuR::IS5 (1200 bp) after G616 exuR :: IS5 (1200 bp) after G616
HK952(자손균주)HK952 (offspring strain) ΔptsI::KmRΔ ptsI :: KmR exuR::IS5 (1200 bp) after G616 exuR :: IS5 (1200 bp) after G616
*유전체 분석을 수행한 균주임.Z 는 돌연변이로 인하여 stop codon이 생겨서 premature termination 이 되는 경우임. * Strains were subjected to genome analysis. Z is a premature termination due to a stop codon due to mutation.
또한, HK864의 자손균주인 HK878에서는 N-Acetylgalactosamine 억제자를 코딩하고 있는 agaR 유전자의 256 bp의 염기서열(C239 ~ C494)이 반복되어 있는 것을 확인할 수 있었으며, HK881에서는 agaR 유전자의 469번째 염기가 G 에서 A로 치환된 돌연변이를 확인하였다. 다른 자손 균주인 HK879와 HK880의 agaR 유전자 부위를 PCR로 증폭하여 Sanger sequencing 방법으로 염기서열을 분석하였을 때, 각각 다른 염기치환 돌연변이가 도입되었음을 확인하였다 (표 6). In addition, in HK878, a progeny strain of HK864, 256 bp sequences (C239 to C494) of the agaR gene encoding the N-Acetylgalactosamine inhibitor were repeated. In HK881, agaR Mutations in which the 469th base of the gene was substituted for G to A were identified. When agaR gene regions of HK879 and HK880, which are different progeny strains, were amplified by PCR and analyzed by sequencing method, it was confirmed that different base substitution mutations were introduced (Table 6).
균주Strain 유전자형genotype 적응진화 돌연변이Adaptive evolution mutations
대장균 C균주      Escherichia coli C strain KCTC2571KCTC2571 manX::IS manX :: IS --
HK864(모균주)HK864 (parent strain) manX::ISΔptsG::KmR manX :: ISΔ ptsG :: KmR --
HK878* (자손균주)HK878 * (offspring strain) manX::ISΔptsG::KmR manX :: ISΔ ptsG :: KmR tandem repeats (C239-C494) in agaR tandem repeats (C239-C494) in agaR
HK879 (자손균주)HK879 (offspring strain) manX::ISΔptsG::KmR manX :: ISΔ ptsG :: KmR agaR C398A (A133E) agaR C398A (A133E)
HK880 (자손균주)HK880 (offspring strain) manX::ISΔptsG::KmR manX :: ISΔ ptsG :: KmR agaR C203T (A68V) agaR C203T (A68V)
HK881* (자손균주)HK881 * (offspring strain) manX::ISΔptsG::KmR manX :: ISΔ ptsG :: KmR agaR G469A (G157R) agaR G469A (G157R)
*유전체 분석을 수행한 균주임.* Strains were subjected to genome analysis.
따라서 ptsG, manX 복수결실 BW25113 모균주와 ptsI 단일결실 BW25113 모균주로부터 혐기조건에서 적응진화를 통하여 성장속도가 빨라지고 숙신산 생산량과 생산성이 증가된 자손균주는 exuR 유전자의 돌연변이를 가지는 것을 확인하였고, manX ptsG 복수결실 대장균 C 모균주는 agaR 유전자의 돌연변이를 통해 숙신산 생산성이 크게 증가되는 것을 확인하였다. Therefore, ptsG, manX plurality deletion BW25113 parent strain BW25113 and ptsI single deletions by the adaptive evolution in anaerobic conditions from the parent strain to grow faster and succinic acid production and the increased productivity progeny strains is exuR Was confirmed to have a mutation of a gene, ptsG manX plurality deletion of E. coli C parent strain was confirmed that the succinic acid productivity is significantly increased by the mutation of the gene agaR.
<실시예 4> <Example 4> exuRexuR  And agaRagaR 유전자의 돌연변이 통한 숙신산 생산량 증가 Increasing Succinate Production Through Mutation of Genes
확인된 돌연변이 형질이 모균주와 비교하여 균주의 성장 회복 및 숙신산 생산량 증가에 영향을 주는지를 확인하기 위하여 exuRagaR 단일 유전자 결실을 모균주에 도입하고자 하였다. K-12 BW25113 모균주인 HK907 균주와 C (KCTC2571) 균주의 모균주인 HK864 균주는 수용균주로 사용하기 위하여 상기 실시예 1에서와 같이 pCP20 플라스미드를 사용하여 카나마이신 항생제 저항성 유전자를 제거하는 과정을 수행하여 각각 HK918 및 HK902 균주를 제작하였다. HK918 균주에 exuR 단일 유전자 결실 형질을 가지는 P1 lysate를 제조하여 감염시켜 P1 transduction을 수행한 결과, 대장균 K-12 BW25113 균주 background에서 ptsG, manX exuR 유전자 결실 돌연변이를 갖는 HK966 균주를 제작하였다. ExuR and agaR to determine if the identified mutant traits affect the growth recovery and succinic acid production of the strain compared to the parent strain A single gene deletion was intended to be introduced into the parent strain. HK907 strain, a parent strain of K-12 BW25113, and HK864 strain, a strain of C (KCTC2571) strain, were used to remove the kanamycin antibiotic resistance gene using the pCP20 plasmid as in Example 1 above. HK918 and HK902 strains were produced, respectively. P1 lysate was prepared by infecting HK918 strain with exuR single gene deletion trait, and P1 transduction was performed. In the background of E. coli K-12 BW25113 strain, ptsG, manX And an HK966 strain with exuR gene deletion mutations.
또한, HK918 균주에 ptsG, manX 결실 및 agaR 유전자가 결실되고 aga operon을 구성하는 유전자군 (agaWEFA)이 도입된 HK923 균주를 제작하였다. aga operon을 구성하는 유전자군 (agaWEFA)는 K-12 BW25113 균주에는 결실되어 있기 때문에, 전사조절인자를 암호화하고 있는 유전자인 agaR 유전자가 결실되고 aga operon이 암호화 하고 있는 Aga 당수송단백질복합체를 통해서 포도당이 세포내로 유입되도록 하기 위하여 aga operon을 구성하는 유전자군을 K-12 BW25113 균주에 도입하였다. 구체적으로 agaR 유전자 부위가 카나마이신으로 치환된 K-12 BW25113 균주를 KEIO collection으로부터 입수하여 agaR::KmR 부위를 포함하도록 PCR 증폭하여 PCR 산물을 얻고, lambda phage의 αβγ 유전자를 포함하고 있어 linear DNA의 homologous recombination을 유도하는 플라스미드 pKD46이 형질전환 되어 있는 HK902 균주에 상기의 PCR산물을 electroporation을 통하여 도입하여 agaR 유전자가 카나마이신 항생제 저항성 유전자로 치환되어 있는 C (KCTC2571) 균주인 HK919 균주를 얻었다. HK909 균주에 P1 박테리오파지를 감염시켜 P1 lysate로 제작하였고, 이를 K-12 BW25113의 수용균주인 HK918 균주에 도입하여 HK923 균주를 제작하였다. 제작된 HK966 및 HK923 균주들을 혐기조건에서 배양하여 균주의 성장과 최종 발효산물의 유기산을 분석한 결과는 표 7에 정리하였다. 이때 aga operon 유전자군의 유무는 각 aga+ gam+ 혹은 aga- gam- 로 나타내었다.In addition, the HK918 strain ptsG, manX agaR deletion and gene deletion and aga An HK923 strain into which the gene group constituting the operon ( agaWEFA ) was introduced was prepared. aga The gene group constituting the operon ( agaWEFA ) is deleted in the K-12 BW25113 strain, and thus the agaR gene, which is a gene encoding a transcriptional regulator, is deleted. In order to introduce glucose into cells through the Aga sugar transport protein complex encoded by the aga operon, a gene group constituting the aga operon was introduced into the K-12 BW25113 strain. Specifically, the K-12 BW25113 strain in which the agaR gene region was substituted with kanamycin was obtained from the KEIO collection, and PCR amplified to include the agaR :: KmR region, thereby obtaining a PCR product, and containing the αβγ gene of lambda phage, thus homologous linear DNA. the HK902 strain which is transformed with the plasmid pKD46 to induce recombination of the introduced PCR products via electroporation to obtain a C (KCTC2571) strain HK919 strain which is substituted with a gene agaR kanamycin antibiotic resistance gene. P1 bacteriophage was infected with HK909 strain to prepare P1 lysate, which was then introduced into the HK918 strain, which is a receiving strain of K-12 BW25113, to prepare a HK923 strain. The resulting HK966 and HK923 strains were cultured under anaerobic conditions to analyze the growth of the strain and the organic acid of the final fermentation product. The presence or absence of aga operon gene group is represented by aga + gam + or aga-gam- respectively.
HK966 균주는 50 mM 포도당을 소모하는데 36시간이 소요되고, 잔당이 2.3 mM 남았으며, 젖산이 생산되지 않고 33.0 mM 의 숙신산이 생산되는 것으로 나타났다. 따라서, HK904 모균주에 비해서 숙신산 생산량은 1.3 mM 증가하였고, 생산성은 2.4배 증가하였다. The HK966 strain took 36 hours to consume 50 mM glucose, remained 2.3 mM of residual sugar, and produced 33.0 mM of succinic acid without lactic acid. Thus, succinic acid production increased 1.3 mM and productivity increased 2.4 times compared to HK904 parent strain.
또한 HK923 균주의 경우에는 50 mM 포도당을 모두 소모하는데 18시간이 소요되고, 젖산이 1.9 mM 생산되고 숙신산은 12.3 mM 생산되는 것으로 확인되었다. 이 결과를 통해서 대장균 K-12 BW25113 균주 background 에서는 ptsG, manX 유전자 결실 일 경우에 exuR 유전자 결실이 도입되면 숙신산 생산이 증가하는 것을 확인할 수 있으며, agaR 유전자 결실 및 aga operon의 도입으로 인한 성장속도는 매우 빨라지지만, 숙신산 생산 증가는 관찰할 수 없었다.In addition, in the case of HK923 strain, it took 18 hours to consume all 50 mM glucose, produced 1.9 mM lactic acid and produced 12.3 mM succinic acid. In through the results of E. coli K-12 strain BW25113 background in case of ptsG, manX gene deletion exuR It can be seen that the production of succinic acid increases when the gene deletion is introduced, The growth rate was very fast due to agaR gene deletion and introduction of aga operon, but no increase in succinic acid production was observed.
대장균 K-12 균주Escherichia coli K-12 strain OD600 OD 600 발효산물의 농도 (mM)Fermentation Concentration (mM) 시간 (h)Time (h) 숙신산 생산성(mM/h) Succinic Acid Productivity (mM / h)
포도당glucose 아세트산Acetic acid 에탄올ethanol 개미산Formic acid 젖산Lactic acid 숙신산Succinic acid
BW25113 BW25113 Wild-typeWild-type 5.6 ± 0.15.6 ± 0.1 NDND 34.2 ± 0.234.2 ± 0.2 34.0 ± 0.434.0 ± 0.4 61.7 ± 0.261.7 ± 0.2 9.6 ± 0.29.6 ± 0.2 5.1 ± 0.15.1 ± 0.1 6 6 0.85 0.85
HK907HK907 BW25113 ΔptsGΔmanX BW25113 Δ ptsG Δ manX 3.0 ± 0.13.0 ± 0.1 NDND 44.6 ± 0.244.6 ± 0.2 18.5 ± 0.618.5 ± 0.6 58.5 ± 0.758.5 ± 0.7 NDND 31.7 ± 0.631.7 ± 0.6 84 84 0.38 0.38
HK966HK966 BW25113 ΔptsGΔmanXΔexuR BW25113 Δ ptsG Δ manX Δ exuR 4.3 ± 0.24.3 ± 0.2 2.3 ± 0.32.3 ± 0.3 32.8 ± 0.332.8 ± 0.3 25.0 ± 0.325.0 ± 0.3 24.9 ± 0.324.9 ± 0.3 NDND 33.0 ± 0.433.0 ± 0.4 3636 0.92 0.92
HK923HK923 BW25113 ΔptsGΔmanXΔagaR(aga+ gam+) BW25113 ptsG Δ Δ Δ manX agaR (aga gam + +) 4.7 ± 0.14.7 ± 0.1 NDND 41.1 ± 0.841.1 ± 0.8 37.5 ± 0.137.5 ± 0.1 56.2 ± 0.656.2 ± 0.6 1.9 ± 0.11.9 ± 0.1 12.3 ± 0.312.3 ± 0.3 18 18 0.68 0.68
대장균 C (KCTC2571) 균주 background에서 ptsGagaR 결실 돌연변이를 갖는 HK919 균주를 상기와 같이 제작하였고, ptsGexuR 결실 돌연변이를 갖는 HK1014 균주는 exuR 단일 유전자 결실 형질을 가지는 P1 lysate를 제조하고 이를 수용균주인 HK902에 감염시켜 P1 transduction을 수행하여 얻었다. 또한, ptsG, agaRexuR 이 결실된 균주인 HK1017 및 HK1015는 다음과 같이 제작하였다. exuR 단일 유전자 결실 형질을 가지는 P1 lysate를 제조하고 HK919에서 pCP20 플라스미드를 이용하여 카나마이신 항생제 저항성 유전자를 제거한 HK976 균주 수용균주로 하여 P1 transduction을 수행하여 ptsG , agaRexuR 유전자가 결실되고 aga operon을 구성하는 유전자인 agaWEFA를 보유하고 있는 (aga+ gam+) HK1015 균주를 제작하였다. 또한, exuR 단일 유전자 결실 형질을 가지는 P1 lysate를 HK912에서 pCP20 플라스미드를 이용하여 카나마이신 항생제 저항성 유전자를 제거한 HK1016 균주를 수용균주로 하여 P1 transduction을 수행하여 aga operon을 구성하는 유전자인 agaWEFA가 결실되어 있는 (aga- gam-) HK1017 균주를 제작하였다. HK1015 및 HK1017은 aga operon의 유무가 차이가 있으며, HK1017균주는 전사조절인자인 ExuR 의 결실로 인하여 당수송단백질인 ExuT로 포도당이 수송되도록 추가적으로 aga operon을 결실시켜 주었다. 이 균주들을 혐기조건에서 배양하여 균주의 성장과 최종 발효산물의 유기산을 분석하였다. 그 결과는 표 8에 나타내었다. HK919 strains with ptsG and agaR deletion mutations in the E. coli C (KCTC2571) strain background were prepared as above, and HK1014 strains with ptsG and exuR deletion mutations prepared P1 lysate with exuR single gene deletion trait and were the recipient strains. It was obtained by infection with HK902 and P1 transduction. In addition, the strains HK1017 and HK1015 deleted ptsG , agaR and exuR were prepared as follows. P1 lysate with exuR single gene deletion trait was prepared and ptsG , agaR and exuR were carried out by H1 and B1 strains containing HK976 strain resistant to kanamycin antibiotic resistance using pCP20 plasmid in HK919. A (aga + gam +) HK1015 strain was produced having agaWEFA , a gene deleted and constituting an aga operon. Also, exuR with a P1 lysate with a single gene-deficient trait at HK912 using pCP20 plasmid by the HK1016 strain to remove the kanamycin antibiotic resistance gene into a receiving strain carried the P1 transduction with a gene agaWEFA constituting aga operon is deleted ( aga-gam-) HK1017 strain was prepared. HK1015 and HK1017 have different aga operons, and HK1017 strain is additionally added to transport glucose to the sugar transport protein ExuT due to the deletion of the transcriptional regulator ExuR. aga operon fruited . These strains were cultured under anaerobic conditions to analyze the growth of the strain and the organic acid of the final fermentation product. The results are shown in Table 8.
대장균 C 균주Escherichia coli C strain OD600 OD 600 발효산물의 농도 (mM)Fermentation Concentration (mM) 시간 (h)Time (h) 숙신산 생산성(mM/h) Succinic Acid Productivity (mM / h)
포도당glucose 아세트산Acetic acid 에탄올ethanol 개미산Formic acid 젖산Lactic acid 숙신산Succinic acid
KCTC2571 KCTC2571 manX::IS manX :: IS 5.4 ± 0.15.4 ± 0.1 NDND 32.4 ± 0.432.4 ± 0.4 29.2 ± 0.229.2 ± 0.2 54.2 ± 0.954.2 ± 0.9 17.4 ± 0.117.4 ± 0.1 6.2 ± 0.06.2 ± 0.0 66 1.03 1.03
HK864HK864 KCTC2571 ΔptsG KCTC2571 Δ ptsG 3.5 ± 0.23.5 ± 0.2 NDND 38.9 ± 1.138.9 ± 1.1 29.8 ± 2.229.8 ± 2.2 50.8 ± 2.750.8 ± 2.7 4.2 ± 0.54.2 ± 0.5 22.7 ± 1.622.7 ± 1.6 6666 0.34 0.34
HK1014HK1014 KCTC2571ΔptsG ΔexuR KCTC2571Δ ptsG Δ exuR 4.1 ± 0.14.1 ± 0.1 NDND 32.2 ± 0.532.2 ± 0.5 32.2 ± 0.932.2 ± 0.9 20.2 ± 1.420.2 ± 1.4 NDND 34.4 ± 0.734.4 ± 0.7 2424 1.43 1.43
HK919HK919 KCTC2571 ΔptsG ΔagaR (aga+gam+) KCTC2571 Δ ptsG Δ agaR (aga + gam +) 5.8 ± 0.15.8 ± 0.1 NDND 39.8 ± 0.139.8 ± 0.1 36.2 ± 0.136.2 ± 0.1 55.0 ± 1.355.0 ± 1.3 2.2 ± 0.02.2 ± 0.0 16.8 ± 0.216.8 ± 0.2 99 1.87 1.87
HK1015HK1015 KCTC2571ΔptsG ΔagaR (aga+ gam+) ΔexuR KCTC2571Δ ptsG Δ agaR (aga + gam +) Δ exuR 5.2 ± 0.25.2 ± 0.2 NDND 40.4 ± 0.140.4 ± 0.1 36.2 ± 0.636.2 ± 0.6 50.0 ± 1.050.0 ± 1.0 2.1 ± 0.12.1 ± 0.1 17.0 ± 0.217.0 ± 0.2 1515 1.131.13
HK1017HK1017 KCTC2571 ΔptsG ΔagaR (aga- gam-) ΔexuR KCTC2571 Δ ptsG Δ agaR (aga- gam-) Δ exuR 2.8 ± 0.12.8 ± 0.1 NDND 28.6 ± 0.228.6 ± 0.2 21.9 ± 0.621.9 ± 0.6 10.5 ± 0.110.5 ± 0.1 NDND 42.0 ± 0.342.0 ± 0.3 3636 1.161.16
ptsGexuR 복수 결실 돌연변이 대장균 C 균주인 HK1014 균주는 50 mM 포도당을 소모하는데 24시간이 소요되고, 젖산이 생산되지 않으며, 숙신산이 34.4 mM 생산되는 것으로 확인되었다. 숙신산 생산성은 1.43 (mM/h)로 크게 향상 되었다. 또한 ptsG, agaR 복수 결실 돌연변이 대장균 C 균주인 HK919 균주의 경우는 50 mM 포도당을 모두 소모하는데 9시간이 소요되고, 젖산이 2.2 mM 생산될 때, 숙신산은 16.8 mM 생산되는 것으로 나타났다. 숙신산 생성량은 크지 않지만, 성장속도가 매우 빨라져서 숙신산 생산성이 1.87 (mM/h)로 크게 증가하는 것을 확인하였다. The HK1014 strain, ptsG and exuR multiple deletion mutant Escherichia coli strain C, took 24 hours to consume 50 mM glucose, did not produce lactic acid, and produced 34.4 mM of succinic acid. Succinic acid productivity was significantly improved to 1.43 (mM / h). Also The HK919 strain, ptsG and agaR plural deletion mutant Escherichia coli strains, took 9 hours to consume all 50 mM glucose. When lactic acid was produced at 2.2 mM, succinic acid was produced at 16.8 mM. The amount of succinic acid produced was not large, but the growth rate was very fast, and it was confirmed that the productivity of succinic acid increased significantly to 1.87 (mM / h).
또한, ptsG, agaR 복수 결실 돌연변이 대장균 C 균주에 exuR 유전자 결실을 도입하였을 때도 생산성이 증가하는 것으로 확인되었는데, 이때 aga operon 유무에 따라서 생산성이 달라지는 것으로 나타났다. ptsG , agaR , exuR 복수 결실 돌연변이에 aga operon 이 존재하는 HK1015 균주는 포도당을 모두 소모하는데 15시간이 소요되었고, 숙신산이 17.0 mM 생산되는 것으로 나타났고, 이때의 생산성은 1.13 (mM/h) 인 것으로 나타났다. ptsG , agaR , exuR 복수 결실 및 aga operon 유전자군이 결실된 HK1017 균주는 포도당을 모두 소모하는데 36 시간이 소요되지만, 젖산이 생산되지 않고 숙신산이 42 mM 생산되며 이때의 숙신산 생산성은 1.16 (mM/h) 인 것으로 확인되었다.Also, ptsG, agaR exuR plurality deletion mutation in E. coli C strain Hayeoteul when introducing a gene deletion was confirmed that productivity is increased, this case showed that vary according to the productivity aga operon or not. aga in ptsG , agaR , exuR ascites deletion mutant The HK1015 strain with operon took 15 hours to consume all the glucose and produced 17.0 mM of succinic acid, with a productivity of 1.13 (mM / h). The HK1017 strain , which lacks the ptsG , agaR , exuR multiple deletions, and the aga operon gene family, takes 36 hours to consume all the glucose, but does not produce lactic acid but produces 42 mM succinic acid with a succinic acid productivity of 1.16 (mM / h It was confirmed that).
위 결과를 통해서 대장균 C 균주 background에서 ptsG 유전자 결실인 경우에 exuR 유전자 결실이 도입되면 소모되는 포도당 대비 숙신산 생산량이 증가함을 확인하였고, agaR 유전자 결실로 인하여 숙신산 생산성이 크게 증가하는 것을 확인하였다. If through the above results, the ptsG gene deletion in E. coli C strain background was confirmed that the glucose in the succinic acid production increased by consumption when exuR gene deletion is introduced, agaR It was confirmed that succinic acid productivity greatly increased due to gene deletion.
<< 실시예Example 5>  5> exuRexuR  And agaRagaR 유전자의 돌연변이를 통한  Through mutation of a gene exuTexuT 유전자,gene, agaaga operon의 mRNA 발현 증가 Increasing mRNA expression of operon
상기의 실시예 3 및 실시예 4로부터 ptsG, manX가 결실된 K-12 균주에서는 exuR 유전자의 돌연변이를 통하여 균주의 성장이 회복되며 숙신산 생산성이 증가하는 것을 확인하였으며, ptsG가 결실된 C 균주에서는 agaR 유전자의 돌연변이를 통하여 균주의 성장이 회복되며 숙신산 생산성이 증가하는 것을 확인하였다. exuR 유전자와 agaR 유전자는 각각 ExuR 전사조절인자와 AgaR 전사조절인자를 암호화한다. ExuR 전사조절인자는 D-galacturonate, D-glucuronate와 같은 aldohexuronates의 수송단백질인 ExuT를 코딩하는 유전자인 exuT의 발현을 억제한다고 알려져 있다 (Mata-Gilsinger, M., Ritzenthaler, P., Mol Gen Genet, 1983). 또한 AgaR 전사조절인자는 N-acetylgalactosamine, D-galactosamine의 수송에 관여하는 단백질들을 코딩하고 있는 aga 유전자군(agaZVWEFA)의 발현을 억제한다고 알려져 있다 (Ray, W. K., Larson, T. J., Mol Microbiol, 2004). 따라서 exuR, agaR 유전자의 돌연변이로 인하여 균주의 성장 및 숙신산 생산이 증가하는 이유는 전사조절인자의 상기 exuT 유전자와 aga 유전자군에 대한 발현억제기능이 소실되어서 당수송단백질의 발현이 증가하고, 이를 통해서 포도당이 세포내로 수송되어 대사되는 것으로 예측되었다. From the above Example 3 and Example 4 ptsG, in K-12 strains manX deletion and the growth of the strain recovery through mutations in exuR gene was confirmed that the succinic acid productivity is increased, the C strain of ptsG deletion agaR Through mutation of the gene, the growth of the strain was recovered and it was confirmed that the productivity of succinic acid increased. exuR Genes and agaR genes encode ExuR transcription regulators and AgaR transcription regulators, respectively. ExuR transcription regulators are known to inhibit the expression of exuT , a gene encoding ExuT, a transport protein of aldohexuronates such as D-galacturonate and D-glucuronate (Mata-Gilsinger, M., Ritzenthaler, P., Mol Gen Genet, 1983). AgaR transcription regulators are also known to inhibit the expression of the aga gene family ( agaZVWEFA ), which encodes proteins involved in the transport of N-acetylgalactosamine and D-galactosamine (Ray, WK, Larson, TJ, Mol Microbiol, 2004). . Therefore, the reason for the increase of strain growth and succinic acid production due to mutation of exuR and agaR genes is that the expression inhibitory function of the transcriptional regulator exuT gene and aga gene group is lost, and thus the expression of glycoprotein is increased. Glucose was predicted to be transported into cells and metabolized.
먼저, K-12 균주에 대해서, 대장균 야생형 균주(BW25113) 및 ptsG, manX 가 결실된 모균주(HK907)와 적응진화된 자손균주(HK953)의 exuT 유전자의 발현량을 비교하기 위하여 qRT-PCR을 다음과 같이 수행하였다. K-12 균주의 야생형인 BW25113 균주와 모균주인 HK907 및 자손균주인 HK953 균주를 혐기조건에서 배양 중에 OD600nm=1이 되는 대수기 초반에 배양액을 취하였다. BW25113 균주는 3시간째였으며, 모균주인 HK907 균주는 지연기인 6시간째 및 성장이 시작하는 54 시간째에, 그리고 자손균주인 HK953 균주는 3시간째에 배양액을 취하고 RNA protect bacterial reagent (Qiagen) 용액과 섞은 후, RNAeasy Mini kit (Qiagen)을 이용하여 total RNA를 정제하였다 (도 3). 정제한 total RNA는 NanoDrop을 이용하여 농도를 측정하였고, qRT-PCR을 위한 각 프라이머는 Roche의 Universal Library Assay Design Center (https://lifescience.roche.com)를 이용하여 exuT 유전자 특이적으로 제작하였다 (표 9). 5 ng의 total RNA를 사용하여 cDNA를 합성하고 (50℃, 40분), cDNA 증폭 (amplification; 95℃, 20 sec; 60℃, 1 min; 40 cycle)을 진행하였다. qRT-PCR을 통해 얻은 data는 LightCycler 96 (Roche Diagnostics, Mannheim, Germany) 프로그램을 이용하여 분석하였으며 16S ribosomal RNA 발현정도와 비교한 상대적인 발현량을 분석하였다. 야생형 균주에서의 exuT 유전자의 발현량에 비하여 모균주인 HK907에서 exuT 유전자가 지연기인 3시간 째에서는 거의 발현되지 않았으나 균주의 성장이 확인되는 54시간 째에는 야생형균주에 비하여 약 6.8 배 증가하는 것으로 나타났고, 자손균주인 HK953에서는 41.8 배 증가하는 것으로 나타났다. 따라서 적응진화에 따른 exuR 유전자의 돌연변이로 인하여 exuT 유전자의 발현이 증가하는 것을 확인할 수 있었다 (도 3). 또한 exuT 유전자의 발현증가로 인하여 ExuT 수송단백질을 통해서 포도당이 세포내로 수송될 수 있음을 확인할 수 있었다. First, with respect to the K-12 strain, the Escherichia coli wild type strain (BW25113) and ptsG, manX QRT-PCR was performed as follows to compare the expression levels of exuT genes of the parent strain (HK907) and the adapted progeny strain (HK953). The wild type BW25113 strain of the K-12 strain, the parent strain HK907 and the progeny strain HK953 strain were cultured at the beginning of the logarithmic phase of OD 600nm = 1 during incubation under anaerobic conditions. The strain BW25113 was 3 hours old, and the parent strain HK907 took 6 hours of delay and 54 hours of onset of growth, and the strain of HK953, a progeny strain, took 3 hours of RNA protection bacterial reagent (Qiagen). After mixing with the solution, total RNA was purified using RNAeasy Mini kit (Qiagen) (FIG. 3). Purified total RNA was measured using NanoDrop, and each primer for qRT-PCR was determined using Roche's Universal Library Assay Design Center (https://lifescience.roche.com). exuT gene was specifically produced (Table 9). CDNA was synthesized using 5 ng of total RNA (50 ° C., 40 minutes), and cDNA amplification (95 ° C., 20 sec; 60 ° C., 1 min; 40 cycles) was performed. Data obtained through qRT-PCR were analyzed using the LightCycler 96 (Roche Diagnostics, Mannheim, Germany) program, and the relative expression levels compared to the expression level of 16S ribosomal RNA were analyzed. In wild-type strains In the parent strain HK907 compared to the expression level of the gene exuT exuT Although the gene was hardly expressed at the 3 hour delay period, the growth rate of the strain was about 6.8 times higher than that of the wild type strain, and 41.8 times higher than that of the progeny strain HK953. Therefore exuR according to adaptive evolution It was confirmed that the expression of the exuT gene is increased due to the mutation of the gene (FIG. 3). In addition, it was confirmed that glucose can be transported into cells through ExuT transport protein due to increased expression of exuT gene.
C 균주에 대해서, 대장균 야생형 균주(KCTC2571) 및 ptsG 가 결실된 모균주(HK864)와 적응진화된 자손균주(HK878)의 agaV, agaB 유전자의 발현량을 비교하기 위하여 qRT-PCR을 수행하였다. C 균주는 야생형인 KCTC2571 균주와 모균주인 HK864 및 자손균주인 HK878 균주를 혐기조건에서 배양 중에 OD600nm=1이 되는 대수기 초반에 배양액을 취하였다. KCTC2571 균주는 3시간째였으며, 모균주인 HK864 균주는 지연기인 12시간 째 및 성장이 시작되는 54시간째에, 그리고 자손균주인 HK878 균주는 3시간째에 배양액을 취하고 RNA protect bacterial reagent (Qiagen) 용액과 섞은 후, RNAeasy Mini kit (Qiagen)을 이용하여 total RNA를 정제하였다. qRT-PCR은 상기와 같이 진행하였고, qRT-PCR을 위한 프라이머는 agaV, agaB 유전자에 특이적으로 제작하였다 (표 9). 야생형 균주 및 모균주인 HK864 균주에서는 agaV, agaB 유전자의 발현량이 거의 비슷한 것으로 나타났고, 모균주의 성장이 확인되는 54시간째에는 야생형균주에 비하여 약 3.3 배 증가하는 것으로 확인되었다. 또한, 자손균주인 HK878에서는 3.8 배 증가하는 것으로 나타났다. 따라서 적응진화에 따른 agaR 유전자의 돌연변이로 인하여 agaV, agaB 유전자의 발현이 증가하는 것을 확인할 수 있었다 (도 4). 또한 aga 유전자군의 발현증가로 인하여 Aga 수송단백질을 통해서 포도당이 세포내로 수송될 수 있음을 확인할 수 있었다. For C strain, E. coli wild type strain (KCTC2571) and ptsG QRT-PCR was performed to compare the expression levels of the agaV and agaB genes of the parent strain (HK864) and the adapted progeny strain (HK878). C strains were cultured at the beginning of the logarithmic phase of OD 600nm = 1 during culturing of wild type KCTC2571 strain, parent strain HK864 and progeny strain HK878 strain under anaerobic conditions. KCTC2571 strain was 3 hours, the parent strain HK864 strain was delayed at 12 hours and growth started at 54 hours, and progeny strain HK878 strain was taken at 3 hours and RNA protect bacterial reagent (Qiagen) After mixing with the solution, total RNA was purified using RNAeasy Mini kit (Qiagen). qRT-PCR was performed as described above, and the primers for qRT-PCR were specifically constructed for agaV and agaB genes (Table 9). The expression levels of agaV and agaB genes in the wild-type strain and the parent strain HK864 were found to be almost the same, and at the 54 hours when the growth of the parent strain was confirmed, it was found to increase about 3.3 times compared to the wild-type strain. In addition, the progeny strain HK878 was found to increase by 3.8 times. Therefore, it was confirmed that the expression of agaV , agaB gene is increased due to the mutation of the agaR gene according to the adaptive evolution (Fig. 4). Also aga Due to the increased expression of the gene group, it was confirmed that glucose can be transported into the cell through the Aga transport protein.
결론적으로, 대장균에서 ptsG, manX , ptsI 와 같은 당 수송계 유전자가 결실된 경우 ExuT 당수송단백질 또는 Aga 당수송단백질복합체를 통하여 세포내로 포도당이 수송될 수 있음을 확인하였다.As a result, it was confirmed that when the transport system, such as a gene per ptsG, manX, ptsI in the E. coli deletions into the cell via a transport protein or Aga glucose transport protein complex per ExuT that glucose can be transported.
서열번호SEQ ID NO: 프라이머 이름Primer name 프라이머 염기서열 (5‘→3’)Primer sequence (5 '→ 3')
1One 16S-Fw16S-Fw CAGCAGCCGCGGTAATACCAGCAGCCGCGGTAATAC
22 16S-Rev16S-Rev ACCAGGGTATCTAATCCTGTACCAGGGTATCTAATCCTGT
33 exuT_RTFexuT_RTF TTCGATTGGTGCGATGATTTTCGATTGGTGCGATGATT
44 exuT_RTRexuT_RTR CCAGCTGTGCATTACGATTGCCAGCTGTGCATTACGATTG
5 5 agaV_RTFagaV_RTF CCGAAGATCCGGTACAACAACCGAAGATCCGGTACAACAA
66 agaV_RTRagaV_RTR TTTTGCAGCGTCCAGAAACTTTTGCAGCGTCCAGAAAC
7 7 agaB_RTFagaB_RTF TGATAACCGTCTGGTTCATGGTGATAACCGTCTGGTTCATGG
88 agaB_RTRagaB_RTR CGACTACCAGCAGATTTGCACCGACTACCAGCAGATTTGCAC
이상으로 본 발명의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시예일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다. Having described the specific parts of the present invention in detail, it will be apparent to those skilled in the art that such specific descriptions are merely preferred embodiments, and thus the scope of the present invention is not limited thereto. will be. Thus, the substantial scope of the present invention will be defined by the appended claims and their equivalents.
Figure PCTKR2018005742-appb-I000001
Figure PCTKR2018005742-appb-I000001
Figure PCTKR2018005742-appb-I000002
Figure PCTKR2018005742-appb-I000002
Figure PCTKR2018005742-appb-I000003
Figure PCTKR2018005742-appb-I000003

Claims (15)

  1. 숙신산 생산능이 향상된, manXptsG 유전자가 결실된 대장균 K-12 균주에 추가적으로 exuR 유전자가 결실된 대장균 K-12 변이 균주.Succinic acid producing ability improved, and manX ptsG gene in addition to the E. coli K-12 strain deleted exuR gene is the E. coli K-12 mutant strain deleted.
  2. 숙신산 생산능이 향상된, manXptsG 유전자가 결실된 대장균 K-12 균주에 추가적으로 agaR 유전자가 결실된 대장균 K-12 변이 균주.Succinic acid producing ability improved, and manX ptsG gene in addition to the E. coli K-12 strain deleted agaR gene is the E. coli K-12 mutant strain deleted.
  3. 숙신산 생산능이 향상된, manXptsG 유전자가 결실된 대장균 K-12 균주에 추가적으로 exuRagaR 유전자가 결실된 대장균 K-12 변이 균주.Succinic acid producing ability improved, and manX ptsG gene with a further exuR and agaR gene deletion in the deletion of E. coli K-12 strain E. coli K-12 mutant strain.
  4. 숙신산 생산능이 향상된, manXptsG 유전자가 결실된 대장균 C 균주에 추가적으로 exuR 유전자가 결실된 대장균 C 변이 균주.Succinic acid producing ability improved, manX ptsG gene and the gene deletion with the deletions are additionally exuR E. coli C strain E. coli C strain variation.
  5. 제4항에 있어서, 상기 대장균 C 변이 균주는 수탁번호 KCTC13265BP로 기탁된 것을 특징으로 하는 대장균 C 변이 균주. The E. coli C mutant strain according to claim 4, wherein the E. coli C variant strain has been deposited with accession number KCTC13265BP.
  6. 숙신산 생산능이 향상된, manXptsG 유전자가 결실된 대장균 C 균주에 추가적으로 agaR 유전자가 결실된 대장균 C 변이 균주.Succinic acid producing ability improved, manX ptsG gene and the gene deletion with the deletions are additionally agaR E. coli C strain E. coli C strain variation.
  7. 숙신산 생산능이 향상된, manXptsG 유전자가 결실된 대장균 C 균주에 추가적으로 exuRagaR 유전자가 결실된 대장균 C 변이 균주.Succinic acid producing ability improved, and manX ptsG gene with a further exuR and agaR gene deletion in the deletion strain of E. coli E. coli C C mutant strain.
  8. 제7항에 따른 대장균 C 변이 균주에 추가적으로 agaW, agaE, agaFagaA가 결실된, 숙신산 생산능이 향상된 대장균 C 변이 균주.E. coli C mutant strains with improved succinic acid production capacity of agaW , agaE , agaF and agaA in addition to the E. coli C variant strain according to claim 7.
  9. 제8항에 있어서, 상기 대장균 C 변이 균주는 수탁번호 KCTC13266BP로 기탁된 것을 특징으로 하는 대장균 C 변이 균주.The E. coli C mutant strain according to claim 8, wherein the E. coli C variant strain has been deposited with accession number KCTC13266BP.
  10. ptsI 유전자가 결실된 대장균 K-12 균주의 적응 진화(adaptive evolution) 배양 방법을 통해 얻은 균주로서, exuR 유전자가 추가적으로 결실된, 숙신산 생산능이 향상된 대장균 K-12 변이 균주. ptsI gene is evolutionary adaptation of the E. coli K-12 strain deleted (adaptive evolution) strain as obtained by the culture method, enhanced E. coli K-12 mutant strain the gene is exuR additional deletion, succinic acid production ability.
  11. 제10항에 있어서, 상기 적응 진화 배양 방법은 카나마이신이 포함된 배지에서 혐기 조건으로 배양하는 것을 특징으로 하는 숙신산 생산능이 향상된 대장균 K-12 변이 균주.The E. coli K-12 mutant strain having improved succinic acid production capacity according to claim 10, wherein the adaptive evolution culture method is cultured under anaerobic conditions in a medium containing kanamycin.
  12. 제10항에 있어서, 상기 대장균 K-12 변이 균주는 수탁번호 KCTC13264BP로 기탁된 것을 특징으로 하는 대장균 K-12 변이 균주.The E. coli K-12 mutant strain according to claim 10, characterized in that deposited with the accession number KCTC13264BP.
  13. 숙신산 생산능이 향상된, ptsI 유전자가 결실된 대장균 K-12 균주에 추가적으로 exuR 유전자가 결실된 대장균 K-12 변이 균주.E. coli K-12 mutant strain having exuR gene deletion in addition to E. coli K-12 strain having ptsI gene having improved succinic acid production capacity.
  14. 제1항 내지 제13항 중 어느 한 항에 따른 변이 균주를 배양하는 단계; 및Culturing the variant strain according to any one of claims 1 to 13; And
    상기 배양액으로부터 숙신산을 수득하는 단계를 포함하는 숙신산의 생산방법.Succinic acid production method comprising the step of obtaining succinic acid from the culture.
  15. 제14항에 있어서, 상기 배양하는 단계는 혐기 조건에서 수행되는 것을 특징으로 하는 숙신산의 생산방법.The method of claim 14, wherein the culturing is performed under anaerobic conditions.
PCT/KR2018/005742 2017-05-19 2018-05-18 Mutant microorganism having enhanced succinic acid production capacity and succinic acid production method using same WO2018212627A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2017-0062315 2017-05-19
KR1020170062315A KR101902190B1 (en) 2017-05-19 2017-05-19 Mutant microorganism with enhanced succinic acid-producing capability and method for producing succinic acid using the same

Publications (1)

Publication Number Publication Date
WO2018212627A1 true WO2018212627A1 (en) 2018-11-22

Family

ID=63721456

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/005742 WO2018212627A1 (en) 2017-05-19 2018-05-18 Mutant microorganism having enhanced succinic acid production capacity and succinic acid production method using same

Country Status (2)

Country Link
KR (1) KR101902190B1 (en)
WO (1) WO2018212627A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102128031B1 (en) * 2018-10-02 2020-06-30 이화여자대학교 산학협력단 An Escherichia coli adapted to methanogenic co-culture and producing succinate from waste glycerol by using adapted Escherichia coli

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011163128A1 (en) * 2010-06-21 2011-12-29 William Marsh Rice University Engineered bacteria produce succinate from sucrose
KR20160142057A (en) * 2015-06-02 2016-12-12 인하대학교 산학협력단 Novel Recombinant Microorganism Producing Organic Acid, And Method for Producing Organic Acid Using the Same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011163128A1 (en) * 2010-06-21 2011-12-29 William Marsh Rice University Engineered bacteria produce succinate from sucrose
KR20160142057A (en) * 2015-06-02 2016-12-12 인하대학교 산학협력단 Novel Recombinant Microorganism Producing Organic Acid, And Method for Producing Organic Acid Using the Same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HU , ZONGLIN ET AL.: "Genetic Analysis of the Roles of AgaA, Agal, and AgaS Genes in the N-acetyl-D-galactosamine and D-galactosamine Catabolic Pathways in Escherichia Coli Strains 0157:H7 and C", BMC MICROBIOLOGY, vol. 13, 2013, pages 1 - 16, XP021150599 *
ROBERT-BAUDOUY, JANINE ET AL.: "Regulation of Hexuronate System Genes in Escherichia Coli K-12: Multiple Regulation of the Uxu Operon by ExuR and UxuR Gene Products", JOURNAL OF BACTERIOLOGY, vol. 145, no. 1, 1981, pages 211 - 220, XP055555660 *
STEIN SIEK, SONJA ET AL.: "Glucose Transport in Escherichia Coli Mutant Strains with Defects in Sugar Transport Systems", JOURNAL OF BACTERIOLOGY, vol. 194, no. 21, 2012, pages 5897 - 5908, XP055555654 *

Also Published As

Publication number Publication date
KR101902190B1 (en) 2018-09-28

Similar Documents

Publication Publication Date Title
WO2019027267A2 (en) Atp phosphoribosyltransferase mutant and l-histidine production method using same
WO2013162274A1 (en) Novel strain producing d-lactic acid and use thereof
WO2016021932A1 (en) Feedback-resistant acetohydroxy acid synthase variant and method for producing l-valine using same
WO2019117398A1 (en) Microorganism producing 5&#39;-inosine monophosphate and method for producing 5&#39;-inosine monophosphate by using same
WO2019203436A1 (en) Acid-resistant yeast with supressed ethanol production pathway and method for producing lactic acid using same
WO2014003439A1 (en) Kluyveromyces marxianus strain having blocked ethanol production pathway, and use thereof
WO2014208981A1 (en) Microorganism with enhanced l-lysine productivity and method for producing l-lysine by using same
WO2019190193A1 (en) Microorganism having enhanced glycine productivity and method for producing fermented composition by using same
WO2020075986A2 (en) Recombinant acid-resistant yeast in which alcohol production is inhibited and method for producing lactic acid by using same
WO2015170907A1 (en) Microorganism having improved l-lysine productivity and method for producing l-lysine using same
WO2017036903A1 (en) Improved vitamin production
WO2011052819A1 (en) Novel method for producing 3-hydroxypropionic acid from glycerol
WO2018212627A1 (en) Mutant microorganism having enhanced succinic acid production capacity and succinic acid production method using same
WO2015122569A1 (en) Recombinant microorganism of genus escherichia with l-threonine productivity, and method for producing l-threonine using same
WO2014126384A1 (en) Recombinant escherichia coli strain with l-threonine productivity and method for producing l-threonine using same
WO2013187733A1 (en) Variant microorganism able to produce large amount of fermentation product, and fermentation product production method using same
Poshekhontseva et al. Streptomyces tsukubensis VKM Aс-2618D—an Effective Producer of Tacrolimus
Imaizumi et al. Improved production of L-lysine by disruption of stationary phase-specific rmf gene in Escherichia coli
WO2015199406A1 (en) Escherichia sp. microorganism having l-tryptophan production capacity and method for producing l-tryptophan using same
WO2015046978A1 (en) Recombinant microorganism having enhanced ability to produce 2,3-butanediol and method for producing 2,3-butanediol using same
CN111548980B (en) Recombinant erythromycin engineering bacterium, and construction method, screening method and application thereof
KR100652186B1 (en) -53 Novel Bacillus Subtilis Subsp. Subtilis A-53 and Method for Preparing Cellulase Using the Same
US20200239831A1 (en) Novel microorganism having minimal genome and method of producing the same
CN109929853B (en) Application of thermophilic bacteria source heat shock protein gene
CN115678817A (en) Recombinant microorganism, preparation method thereof and application thereof in threonine production

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18803017

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18803017

Country of ref document: EP

Kind code of ref document: A1